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Pregnancies complicated by maternal diabetes are associated with 
increased risk of birth defects. Interestingly, the types of malformations that show 
elevated risk in diabetic pregnancy are similar to those caused by disrupted 
embryonic retinoic acid (RA) levels. RA is an important signaling molecule 
involved in the development of many organ systems in the embryo. Embryonic 
RA levels are tightly regulated by the RA synthesizing enzyme retinal 
dehydrogenase (Raldh) that has 3 isoforms, Raldhl, Raldh2 and Raldh3. This 
project aimed to investigate whether there was any dysregulation of RA synthesis 
in embryos of diabetic mice that might increase the risk of malformations.. 
First, to determine whether maternal diabetes affected RA synthesis, 
embryos of streptozotocin-induced diabetic and non-diabetic mice on and 
9th day of gestation (E) were collected for detection of Raldhl, Raldh2 and RaldhS 
mRNA expressions by in situ hybridization and real-time quantitative reverse 
transcription-polymerase chain reactions. Moreover, different isoforms of Raldh 
enzymes were separated by isoelectric focusing, followed by determining their 
RA synthesizing activities using an in vitro bioassay. Results showed that 
expressions of all Raldh isoforms were significantly down-regulated in embryos 
of diabetic mice. Concomitantly, a significant reduction in the in vitro RA 
synthesizing activity of Raldh2 was found in the diabetic group, while the activity 
of Raldhl and RaldhS was below the detection limit of the assay system. 
Next, to determine whether elevated glucose was the critical factor in 
the maternal diabetic milieu that reduced RA synthesis in the embryo, blood 
glucose levels of diabetic mice were specifically reduced by injection of phlorizin, 
which induced renal glucosuria, at 4-hour intervals starting from hour 14 on E8. 
On E9, embryos were collected for analysis of the mRNA expression level of 
Raldh genes and in vitro RA synthesizing activity of Raldh enzymes. Results 
showed that concomitant with a significant reduction in blood glucose levels, the 
expression of Raldhl, Raldh2 and RdldhS and the in vitro RA synthesizing 
activity of Raldh2 enzymes in embryos of diabetic mice were normalized to a 
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level similar to that of embryos of non-diabetic mice. To directly test whether 
glucose could cause dose-dependent changes on RA synthesis, early headfold 
stage rat embryos were cultured in vitro for 48 hours in medium supplemented 
with varying concentrations (2，3 and 4 mg/ml) of D-glucose. Results showed that 
high glucose could indeed cause a dose-dependent reduction of both Raldh2 gene 
expression levels and the Raldh2 in vitro RA synthesizing activity. 
Lastly, to determine whether hyperglycemia-induced reduction in RA 
synthesis would affect embryo development, an in vitro rescue experiment was 
conducted in which headfold stage rat embryos culturing in hyperglycemic 
conditions (3 or 4 mg/ml D-glucose) were supplemented with varying 
concentrations to lO'^ M) of RA. Results showed that while embryos 
cultured in hyperglycemic conditions alone exhibited severe malformations in 
multiple organ systems, supplementation with RA could significantly ameliorate 
hyperglycemia-induced malformations in the embryo in a dose-dependent manner. 
Taken together, results of this thesis show that there is dysregulation of 
RA synthesis under diabetic or hyperglycemic conditions, which increases the risk 
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Chapter 1: General Introduction 
1.1 DIABETES MELLUUS 
Diabetes mellitus (DM) is a chronic metabolic disease resulting from 
either insulin resistance or loss of insulin producing pancreatic p-cells. Regardless 
of the pathological mechanism of DM, DM is characterized by high blood glucose 
concentrations. DM is usually complicated with a variety of diseases, such as 
retinopathy (Rosenstock et al., 1986), nephropathy (Raptis and Viberti, 2001)， 
neuropathy (Trotta et al., 2004) and cardiovascular diseases (Nesto, 2004). 
According to World Health Organization, there were at least 171 
million people worldwide or 2.8% of the population suffering from DM in year 
2000 (Wild et al, 2004). Moreover, the incidence of DM is rapidly increasing. By 
2030, it is estimated that the prevalence of DM will soar to 2-fold as much as that 
in 2000. In western countries, such as United States and European countries, the 
incidence of DM has been increasing considerably. Recently, in the developing 
countries, e.g. Asia and Africa, the prevalence of DM also increases dramatically. 
The change of diet and lifestyle of the people living in these countries may be the 
cause of significant increases in the number of diabetic patients in these countries. 
DM is classified into 3 main types, type 1 diabetes mellitus (TIDM), 
type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM). TIDM 
is a childhood-onset autoimmune disease characterized by the loss of 
pancreatic P-cells, the insulin secreting cells in the body. Since TIDM is caused 
by reduced insulin secretion, it is also known as insulin-dependent diabetic 
mellitus (IDDM) or juvenile-onset diabetes mellitus. T2DM, which is an 
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adult-onset disease, is characterized by insulin resistance. It is also known as 
non-insulin dependent diabetes mellitus (NIDDM), which indicates that the cause 
of T2DM is not due to inability of insulin production in the body, but is due to 
resistance to insulin. GDM, similar to T2DM, is defined as insulin resistance that 
is first recognized during pregnancy. 
1.1.1 lype 1 diabetes mellitus 
TIDM accounts for about 5-10% of the overall diabetic population. 
The etiology of TIDM remains unclear. However, studies on monozygotic and 
dizygotic twins support that both genetic and environmental factors play 
important roles in the etiology of TIDM (Hirschhom, 2003). The concordance of 
TIDM in monozygotic twins is about 50%, whereas it is about 8% in dizygotic 
twins (Hyttinen et al.，2003). 
Genetic studies have revealed that human leukocyte antigen (HLA) 
class II molecules, the DR and DQ a-p heterodimers encoded by the genes in the 
HLA region in human chromosome 6p21.3, are highly associated with the 
increase in susceptibility to TIDM (Davies et al., 1994; Concannon et al., 2005). 
Within the HLA region, there are more than 200 genes, and 40% of the genes are 
predicted to possess immune response functions (Horton et al., 2004). However, 
the mechanism of how the HLA class II molecules result in destruction of 
pancreatic p-cells in TIDM is still not fully understood. It is predicted that 
binding of autoantigens to the HLA class II molecules heterodimers might play a 
critical role in the increased risk of developing TIDM. 
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1.1.2 Type 2 diabetes mellitus 
T2DM is the most common form of diabetes that accounts for 90-95% 
of the overall diabetic population or 5-7% of the population worldwide (King et 
al., 1998). T2DM usually occurs in adults after the age of 40. However, the 
prevalence of T2DM in all age groups is increasing in an alarming rate (Hotu et 
al., 2004; Hossain et al., 2007). For maturity-onset diabetes of the young (MODY), 
adult-onset autoimmune diabetes and rare genetic diseases-related diabetes, each 
of them accounts for 5-10% of the T2DM population (Fajans, 1989，Niskanen et 
al” 1995). The etiology of T2DM in the rest of the 70-85% patients remains 
controversial. 
Although the pathogenesis of T2DM is multi-factorial, genetic and 
environmental factors are two major components in the etiology of T2DM 
(Hamman, 1992). Studies on families and twins have clearly shown that genetic 
inheritance of T2DM is polygenic, which means that simultaneous presence of 
several diabetes-related genes is required for the development of T2DM (Bamett 
et al., 1981; Newman et al., 1987). Insulin insensitivity and impairment of insulin 
secretion are common outcomes resulting from polymorphisms of abnormal genes. 
Two diabetes-related genes, NIDDMl (Hanis, et al., 1996) and NIDDM2 
(Mahtani, et al., 1996), have been identified in controlling the susceptibility of 
T2DM in Mexican Americans and Finnish families. 
Apart from genetics lineage, the etiology of T2DM is also complicated 
by lifestyle. Obesity dramatically increases the risk of developing T2DM (Colditz 
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et al.，1995). In particular, intra-abdominal obesity is believed to be the major 
cause of insulin resistance (Carey et al, 1996). Besides that, sedentary lifestyle or 
physical inactivity will further increase the risk of susceptibility to T2DM, 
independent to obesity (Mokdad et al, 2001; Kaufman, 2002). Moreover, 
cigarette smoking and low fiber diet with high glucose consumption also lead to 
an increased risk of T2DM (Chandalia et al., 2000; Manson et al., 2000). Hence, 
change of lifestyle, such as weight loss, regular exercise, having diet containing 
high fibers and low glucose, and abstinence from smoking all are beneficial for 
preventing the development of T2DM and also alleviating the severity of t2DM. 
1.1.3 Gestational diabetes mellitus 
GDM is defined as insulin resistance or glucose intolerance that is first 
recognized during pregnancy. In the United States, according to the National 
Diabetes Fact Sheet, about 3-5% of overall pregnancies develop GDM per year 
(Ben-Haroush et al” 2004). Women with GDM show a higher frequency to give 
birth to babies with excess birth weight (Schaefer-Graf et al, 2005). 
Some literatures have revealed the underlying long term complications 
of GDM. It has been reported that there is at least a 7-fold increase in the risk of 
developing T2DM in women who have GDM compared with those that have 
normoglycemic pregnancy (Bellamy et al., 2009). Genetic screening of particular 
loci may help to identify the risk of development from GDM to T2DM after 
gestation (Lauenborg et al, 2009). 
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1.2 DIABETIC PREGNANCY 
1.2.1 Incidence of congenital malformations in diabetic pregnancy 
The incidence of diabetic pregnancy accounts for about 6-8% in the 
western countries, including the United States and European countries, but rises 
up to 15-20% in the developing countries. The infant of diabetic mother has a 
greater susceptibility in developing congenital malformations and adverse 
neonatal outcomes (Yang et al., 2006). There is a 3-fold increase in the prenatal 
� mortality rate in the infant of diabetic mother, whereas the mortality rate in the 
first year of life shows a 9-fold increase. Moreover, the infant of mother with 
T2DM suffers 4 times higher risk of perinatal mortality when compared with the 
infant of mother with TIDM. Apart from perinatal mortality, the frequency of 
developing congenital malformations in the infant of diabetic mother is 5 to 11 
times higher than the infant of non-diabetic mother (Dunne et al., 2003). 
Moreover, the infant of diabetic mother shows increased susceptibility to preterm 
delivery, macrosomia, respiratory distress syndrome and neonatal hypoglycemia 
(Cordero et al., 1998; Alam et al., 2006). 
In diabetic pregnancy, including both TIDM and T2DM, the incidence 
of a number of congenital malformations in the infant increases considerably 
(Towner et al., 1995; Farrell et al., 2002). Although tight glycemic control can 
reduce the risk of congenital malformations by 3 fold, the frequency of congenital 
malformations in the infant of diabetic mother is still higher than that of 
non-diabetic mother (Langer and Conway, 2000; Evers et al., 2004). 
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1.2.2 Long term complications in the infant of diabetic mother 
Many studies have shown that offspring of diabetic mothers are more 
susceptible to develop cardiovascular diseases, hypertension, obesity, impaired 
glucose tolerance and T2DM in childhood and adolescent (Pettitt et al.，1983; 
Weintrob et al., 1996; Simeoni and Barker, 2009). Even though the birth weight of 
the infant is normal, the risk of obesity in childhood still increases substantially, 
suggesting that alteration of fat metabolism is disrupted as a result of early 
exposure to hyperglycemia (Pettitt et al., 1987). Moreover, infants are more likely 
to develop T2DM in adulthood if the birth weight exceeds the normal range. 
Previous studies have demonstrated that diabetes can be passed onto the second or 
even the third generation, which may be caused by an inherited defect in 
mitochondrial oxidative phosphorylation, leading to dysregulation of 
intramyocellular fatty aicd metabolism (Petersen et al., 2004). Reduced insulin 
secretion and sensitivity are believed to be acquired as early as after in utero 
exposure to high maternal glucose concentrations during gestation. 
1.3 HYPERGLYCEMIA 
Diabetes pregnancy is characterized by hyperglycemia, 
hyperketonemia, hypertriglyceridemia, and increase in somatomedin binding 
proteins and oxidative stress. Among these factors that are altered in diabetic 
pregnancy, hyperglycemia is shown to damage insulin secretion and impair insulin 
sensitivity (Rossetti et al., 1990). In diabetic pregnancy, hyperglycemia is believed 
to be one of the most common factors for increasing the risk of congenital 
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malformations. The elevated amount of glucose can be transported across the 
placenta from the mother to the embryo (Illsley, 2000). Moreover, animal studies 
on the teratogenicity of hyperglycemia have shown that induction of 
hyperglycemia in vivo at the day prior to formation of neural tube closure could 
mimic the effect of maternal diabetes in increasing the risk of neural tube defects 
in the embryo. Moreover, transient reduction of maternal blood glucose level 
could reduce the incidence of neural tube defects in embryos of diabetic mice 
(Fine et al., 1999). These findings suggest that hyperglycemia is responsible for 
the teratogenic effect of the diabetic maternal milieu on embryo development. 
1.4 OXIDATIVE STRESS 
1.4.1 Oxidative stress and antioxidant enzymes 
In diabetic pregnancy, the oxidative stress in embryos is up-regulated 
when compared with that in normal pre^ancy. A small proportion, around 0.1-5%, 
of oxygen enters the electron transport chain to produce energy in the form of ATP 
(Droge, 2002). During oxidative phosphorylation, some leakage of activated 
oxygen from the mitochondria may occur resulting in single electron reduction of 
oxygen derivatives, such as hydrogen peroxide, superoxide and the hydroxyl 
radical. The cellular oxidant level is tightly regulated by a group of antioxidant 
enzymes, including catalase (CAT), glucose-6-phosphate dehydrogenase (G6PD), 
superoxide dismutase (SOD), and glutathione peroxidase (GPx), which seryes as a 
defensive system to protect cellular components from the damage of reactive 
oxygen species (ROS). These free radical scavenging enzymes catalyze the 
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conversion of ROS into a more stable form in order to prevent cellular damages. 
I 
1.4.2 Cellular function of oxidative stress 
An optimal level of oxidants is essential for embryonic development. 
The cell fate is controlled by the redox state within the cell via activation or 
suppression of specific transcription factors. A reduced state leads to proliferation, 
whereas a relatively oxidized state promotes differentiation, and further oxidized 
state results in apoptosis. Besides controlling the redox state of the cell, ROS 
plays a role in cell signaling by acting as both primary and secondary messengers. 
ROS can be generated transiently and locally to mediate cellular signaling 
(Hansen, 2006). Moreover, ROS can be induced in large amount by primary 
growth factors, such as epidermal growth factor (EGF), to promote cell growth 
(Sundaresan et al., 1996). 
1.4.3 Adverse effects of excess oxidative stress during embryogenesis 
The level of oxidative stress must be tightly regulated for normal 
embryogenesis. When the rate of production of ROS exceeds the rate of ROS 
scavenging, it generates an imbalance level of oxidants, resulting in oxidative 
stress. During embryogenesis, apoptosis is an essential process during 
morphogenesis of many structures (Haanen and Vermes, 1996; Mirkes, 2002). It is 
found that cells that are undergoing cell death also have higher levels of ROS, 
suggesting that the generation of oxidative stress is involved in the control of 
embryonic cell death (Clarke et al., 1998; Salas-Vidal et al, 1998). For example, 
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interdigital mesenchymal cell death is important for digit individualization of the 
developing limbs (Zuzarte-Luis and Hurle, 2005). However, animal studies have 
showed that reduction of oxidative stress by antioxidant treatment prevented 
interdigital cell death and affected digit formation (Salas-Vidal et al.’ 1998). 
Conversely, high levels of oxidative stress caused by diabetic pregnancy are 
teratogenic and result in different kinds of birth defects, e.g. heart defects and 
neural tube defects (Morgan et al., 2008b; Dheen et al., 2009). 
1.5 RETINOIC ACID 
1.5.1 Function of RA during embryonic development 
All-trans retinoic acid (RA), the derivative of vitamin A (retinol), is an 
indispensible signaling molecule during vertebrate embryonic development. In 
particular, RA signaling is essential for antero-posterior (A-P) body axis 
patterning, somite formation, neural tube closure, limb induction and development 
of a variety of organs including the brain, heart, eyes and kidney. Too much or too 
little RA leads to increased risk of congenital malformations. Embryos with 
disrupted RA homeostasis exhibit major patterning defects along the AP axis and 
in the developing hindbrain (Niederreither et al., 1999; 2000). 
1.5.2 RA synthesis and degradation 
Embryonic RA is synthesized by oxidation of retinol obtained from the 
maternal blood. When retinol is transported in the blood, it is bound to retinol 
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binding protein (RBP) 4 to prevent loss from filtration in the kidney. When the 
retinol-RBP complex reaches the RA generating cell, it enters the cell through a 
cell surface receptor, STRA6. 
RA is synthesized from the precursor retinol by 2 steps. The first step 
is the oxidation of retinol to retinaldehyde catalyzed by several retinol 
dehydrogenases. The second step is the rate-Uniting step. It involves oxidation of 
retinaldehyde to RA catalyzed by the enzyme retinaldehyde dehydrogenase 
(Raldh), which has three isoforms, namely Raldhl, Raldh2 and Raldh3. In tissues 
that have to be devoid of RA, RA will be catabolically inactivated by Cyp26 
enzymes, which belong to the cytochrome P450 family. There are three isoforms, 
namely Cyp26al, Cyp26bl and Cyp26cl. Amongst them, Cyp26al is 
RA-inducible and is the first enzyme identified to be involved in the oxidation of 
RA into more polar derivatives, such as 4-OH and 4-oxo RA (White et al., 1996). 
Both the RA synthesizing and catabolizing enzymes have unique expression 
domains during embryonic development. 
RA is a lipophilic molecule that is able to diffiise across the cell 
membrane. In RA target cells, cellular retinoic acid binding proteins (CRABP) 
transport RA into the nucleus. In the nucleus, upon binding with the retinoic acid 
receptors (RAR) and retinoid X receptors (RXR), the complex will further bind to 
a consensus sequence called the retinoic acid response element (RARE) in the 
promoter region of target genes to trigger transcription. 
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1.5.3 Mechanisms of retinoic acid signaling 
It has been reported that hundreds of genes are inducible by RA, 
however, only about 20 of them are confirmed to possess a RARE (Baimer and 
Blomhoff，2002). Even in the absence of RA binding, the RA receptors, RAR 
(a, p，y) and RXR (a, p, y) form heterodimers and bind to the RARE consensus 
sequence. They recruit co-repressors, such as ligand dependent co-repressor and 
chromatin remodeling complex, to stabilize the chromatin structure. Histone 
methyl-仕ansferase and histone deacetylase are also recruited for stabilizing the 
chromatin complex. In the presence of RA, the RAR-RXR heterodimer binds to 
the RARE consensus sequence and recruits co-activators, instead of co-repressors, 
to activate the target genes. DNA demethylation and acetylation allow the DNA to 
become accessible for transcription. 
1.5.4 Developmental genes regulated by RA 
As mentioned before, the mechanism of RA signaling is characterized 
by the binding of the RA-RA nuclear receptor complex to the target gene. Many 
of the Homeobox (Hox) genes involved in drosophila and vertebrate 
embryogenesis are target genes. Hox genes are a group of genes that is highly 
evolutionary conserved and share a common phylogenetic ancestor. During 
embryogenesis, the spatial and temporal expressions of a set of Hox genes are 
important for A-P patterning, body axis formation, and brain and limb 
development (Wellik, 2007; Alexander et al., 2009). 
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Research studies have demonstrated that the expressions of several 
novel Hox genes are associated with RA signaling during embryonic development. 
Experiments on the embryonal carcinoma cell line NT2/D1 have demonstrated 
that activation of the human Hox2 cluster genes {Hox-2.9, Hox-2.8 and Hox-2.6) 
could be induced by different concentrations of RA (Simeone et al., 1990). 
Moreover, abnormal levels of RA altered the expression level of Hox-C gene, 
resulting in congenital malformations in vertebrate embryos (Conlon and Rossant, 
1992). Taken together, it is suggested that an optimal level of RA is essential for 
the proper expression of particular Hox genes for normal embryonic development. 
Besides Hox genes, sonic hedgehog (Shh) is also a well-known 
RA-related morphogen regulating the development of A-P patterning of the limb, 
dorso-ventral patterning of axial embryonic structures (Johnson et al., 1994) and 
brain formation (Agarwala et al., 2001; Ishibashi et al., 2002; Bayly et al., 2007). 
Shh together with Fgf8 are particularly important for forebrain patterning and 
left-right axis determination during embryogenesis (Meyers and Martin, 1999; 
Ribes et al., 2009). Genetics studies on the Raldh2{-/-) mouse embryos have 
demonstrated that the expression level of FgfS was altered asymmetrically on the 
two sides of the body axis (Vermot et al., 2005) and disrupted expression of Shh 
was also found in the posterior region of the developing limb buds (Mic et al., 
2004). Moreover, a RARE is identified in upstream region of Shh, confirming that 
the expression of Shh can be directly induced by the binding of the RA receptor 
complex in the presence of RA (Chang et al., 1997). Similar to the Hox genes, the 
expression of important developmental genes, such as Shh and FgfS, is also tightly 
associated with the level of RA during embryogenesis. 
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1.6 STRATEGY OF THE THESIS 
The frequency of congenital malformations in infants of diabetic 
mothers is estimated to be 6-10%, a two to five-fold increase compared with 
infants of non-diabetic mothers (Kucera, 1971; Aberg et al. 2001). Moreover, 
diabetic pregnancy is associated with increased risk for several types of birth 
defects, including caudal regression, cleft palate, cardiovascular malformations, 
neural tube defects, limb reduction defects and renal agenesis (Kucera, 1971; Piatt 
and Golde, 1983; Martinez-Frias, 1994; Lynch and Wright, 1997; Loffredo et al., 
2001). Interestingly, this spectrum of defects is very similar to that seen in humans 
and animals in association with disrupted RA levels (Wilson et al, 1953; Lammer 
et al, 1985; Rothman et al., 1995; Shum et al, 1999; Niederreither et al, 2002a; 
Ryckebusch et al., 2008). This similarity suggests that embryopathy caused by 
maternal diabetes and disrupted RA levels may have some common mechanistic 
features. RA homeostasis is tightly regulated by synthesis and degradation. Our 
laboratory has found that the mRNA expression level of the key RA catabolizing 
enzyme Cyp26al is significantly down-regulated in embryos of diabetic mice, 
which results in reduced RA catabolic activity and increases the embryo's 
susceptibility to malformations (Leung, 2005; Lee, 2007). The aim of this thesis 
was to determine whether RA synthesis was dysregulated under diabetic or 
hyperglycemic conditions that might play a role in increasing the risk of 
malformations. 
The first part of the thesis (Chapter 3) was to examine whether there 
was any reduction in RA synthesis in the embryo of diabetic mice. To achieve that, 
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the mRNA expression level and the in vitro RA synthesizing activity of the 3 
Raldh isoforms, Raldh 1, Raldh2 and RaldhS, in embryos of diabetic and 
non-diabetic mice were determined. 
After establishing the fact that there was indeed a significant reduction 
in RA synthesis in embryos of diabetic mice, the second part of the thesis 
(Chapter 4) was to determine whether elevated glucose was the critical factor in 
the maternal diabetic milieu that reduced RA synthesis in the embryo. To achieve 
that, first, I have employed an m vivo approach by reducing the blood glucose 
level of the diabetic mouse to determine whether it could normalize RA synthesis 
in the embryo. Next, I have employed an in vitro approach by culturing rat 
embryos in medium containing varying concentrations of D-glucose to determine 
whether there was any dose-dependent relationship between high glucose and RA 
synthesis in the embryo. 
In the third part of the thesis (Chapter 5)，I have investigated whether 
hyperglycemia-induced reduction in RA synthesis would increase the embryo's 
susceptibility to malformations. An in vitro rescue experiment was performed in 
which rat embryos culturing in hyperglycemic conditions were supplemented with 
varying concentrations of RA to determine if this could alleviate 
hyperglycemia-induced malformations and normalized development of the 
embryo. 
Finally, results were concluded and future perspectives were discussed 
in Chapter 6. 
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2.1 ANIMALS 
The Institute of Cancer Research (ICR) mouse colony was obtained 
from Harlan Laboratories, UK. The Sprague Dawley (SD) rat colony was obtained 
from the Animal Resources Centre at Perth, Australia. Both ICR mice and SD rats 
were random-bred in the Laboratory Animal Services Centre of the Chinese 
University of Hong Kong. They were fed with irradiated LabDiet for rodents 
{PMI Nutrition) and ozone-sterilized tap water. All animal experimentation 
procedures were approved by the Animal Experimentation Ethics Committee of 
the Chinese University of Hong Kong. 
2.2 INDUCTION OF DIABETES 
Diabetes was induced in 8-week-old ICR female virgin mice by 
intraperitoneal injection of streptozotocin {MP Biomedicals). The mouse received 
65 mg/kg body weight of streptozotocin in 3 consecutive days at 4:00 pm. 
Streptozotocin was freshly prepared by dissolving in 0.01 M sodium citrate buffer, 
pH 4.5 prior to each injection. The mouse was checked for diabetes 12 days after 
the first injection. Using a glucometer (Glucometer Elite, Bayer), the glucose level 
in a blood droplet obtained from the tail vein was measured. The blood glucose 
level of non-diabetic mice was in the range of 5-7.8 mmol/1. 
Streptozotocin-injected mice with blood glucose levels reaching 16.7 mmol/1 or 
higher were regarded as diabetic and used for subsequent experiments, whereas 
those with blood glucose levels lower than 16.7 mmol/1 were discarded. Blood 
glucose level of the diabetic mouse was measured again prior to sacrifice for 
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embryo collection to confirm that the diabetic condition sustained during 
pregnancy. Age-matched female ICR mice without streptozotocin injection served 
as the non-diabetic control. 
2.3 MATING METHODS 
2.3.1 Mice 
Mice were kept in a humidity-controlled room free of noise 
disturbance. The light-dark cycle of the room was set as 12:12 hour with the dark 
period starting from 11:00 pm. Timed mating was set up by pairing up one 
diabetic or non-diabetic ICR female mouse with one ICR male mouse 2 hours 
prior to the commencement of the light cycle. At 11:00 am, the female mouse was 
examined for the presence of a copulation plug as an indicator of successful 
mating. Fertilization was assumed to have occurred at 10:00 am and this time 
point was defined as 0 day of gestation (E). Mouse embryos were used for 
experiments in Chapter 3 and Chapter 4. 
2.3.2 Rats 
SD rats were kept in humidity- and noise-controlled conditions under a 
12:12 hour light-dark cycle, with the dark cycle starting from 6:00 pm. Mating 
was set up by pairing up one female SD rat with one male SD rat starting from 
6:00 pm. In the following morning, female rats were examined for the presence of 
a copulation plug. Fertilization was assumed to have occurred in the middle of the 
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dark cycle, i.e. midnight. Noon on the day of finding the copulation plug was 
defined as E0.5. Rat embryos were used for whole embryo culture experiments in 
Chapter 4 and Chapter 5. 
2.4 WHOLE MOUNT HYBRIDIZATION 
All procedures were carried out at room temperature unless indicated otherwise. 
2.4.1 Synthesis of DNA plasmids and riboprobes 
2.4.1.1 Mini-scale preparation of plasmid DNA 
Details of cDNA plasmids used were listed in section 3.3.1.2. 
Transformed bacteria with plasmids containing the target gene were 
grown in 10 ml of LB broth (Invitwgen) added with 80 |ig/ml ampicillin {Roche) 
with vigorous shaking at 37°C overnight. 
At the end of incubation, DNA plasmids were extracted and purified 
by using the Plasmid DNA Extraction Mini Kit {Favorgen) according to the 
manufacturer's protocol. First, the bacteria solution was subjected to 
centrifugation at 3,000 revolutions per minute (rpm) for 15 minutes. The DNA 
plasmid pellet was then re-suspended in 200 i^l of FAPDl buffer, followed by 
addition of 200 of FAPD2 buffer to lyze the cells for 2 minutes. Then 300 i^l of 
FAPD3 buffer was added to precipitate the organelles for 5 minutes, followed by 
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centrifugation at 14,000 rpm for 5 minutes. The supernatant was filtered with a 
FAPD column under centrifugation at 14,000 rpm for 30 seconds. The supernatant 
was discarded and 400 |il of Wash Buffer W1 was added to the column, followed 
by centrifugation at 14,000 rpm for 30 seconds. The column was then washed 
with 750 |il of Wash Buffer and centrifiiged at 14,000 rpm for 30 seconds. To dry 
the column thoroughly, the column without any buffer was centrifiiged at 14,000 
rpm for 3 minutes. Finally, 50 \i\ of Elution Buffer was added to the center of the 
filter column to elute the DNA plasmid by centrifugation at 14,000 rpm for 2 
minutes. 
The quality of the DNA plasmid was checked by gel electrophoresis. 
In addition, the concentration of the DNA plasmid was determined by measuring 
the optical density at the wavelength of 260 nm using a spectrophotometer 
{GeneQuant, Pharmacia Biotech). The DNA plasmid was stored at -20°C. 
2.4.1.2 Linearization of DNA plasmid 
The DNA plasmid was linearized by cutting a particular restriction site 
with the corresponding restriction enzyme depending on the identity of the target 
gene. The reaction mixture for linearization of the DNA plasmid was composed of 
5 |Lig of DNA plasmid, 20 units of restriction enzymes, 5 \i\ of lOX reaction buffer 
and then made up to a final volume of 50 |il with diethylpyrocarbonate 
(DEPC)-treated RNase-free water. The reaction mixture was incubated in a 
thermomixer {Eppendrof) at 37°C for 2 hours. At the end of incubation, the 
linearized DNA was extracted by adding equal volume of 
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phenolxhloroformiisoamyl alcohol (25:24:1, v:v:v) and then centrifuged at 
14,000 rpm for 10 minutes at 4°C. The upper aqueous layer containing the 
linearized DNA was collected and equal volume of chloroform:isoamyl alcohol 
(24:1, v:v) was added. The reaction mixture was centrifuged at 14,000 rpm for 10 
minutes. The upper aqueous layer was collected for DNA precipitation with 0.1 
volume of 3 M sodium acetate and 2 volumes of ice-cold 100% ethanol for 2 
hours at -20°C. The reaction mixture was then centrifuged at 14,000 rpm for 15 
minutes at 4°C. The pellet was washed with 70% ice-cold ethanol and then dried 
by using the DNA Speed Vac {Savant). Finally, the DNA pellet was re-suspended 
in 20 III of DEPC-treated water. 
To confirm the purity of the linearized DNA plasmid, gel 
electrophoresis was used to check the size of the DNA product. The concentration 
of the linearized DNA plasmid was determined by measuring the optical density at 
the wavelength of 260 nm. The linearized DNA plasmid was stored at -20°C. 
2.4.1.3 In vitro transcription and labeling 
Antisense RNA probe was synthesized from the linearized DNA 
plasmid by using the appropriate RNA polymerase corresponding to the target 
probe. The probe was labeled by digoxigenin (DIG) RNA labeling nucleotide mix 
{Roche) that contained DIG-labeled UTP. The reaction mixture was composed of 
the following: , 
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Linearized plasmid 1 |ig 
1 OX Transcription buffer 2 \i\ 
DIG RNA labeling nucleotide mix (10 mM) 2 |al 
RNasin ribonuclease inhibitor (40 units/|Lil) 0.5 |il 
RNA polymerase (20 units/|al) 1.5 \x\ 
DEPC-treated water was added to make up a final volume of 20 jil 
The reaction mixture was incubated for 2 hours at 37°C. After in vitro 
transcription, the cDNA template was digested by adding 2 of DNase I (10 
units/|xl, Roche) and incubated for 15 minutes at 37°C. To precipitate the 
DIG-labeled RNA probe, 10 \i\ o f 4 M LiCl, 100 i^l of Tris-EDTA (TE) buffer (pH 
7.4) and 300 |il of ice-cold 100% ethanol were added and then kept at -20�C for 2 
hours. The mixture was then centrifuged at 14,000 rpm for 15 minutes at 4°C and 
the pellet was washed with 700 |LI1 of 70% ice-cold ethanol. The pellet was finally 
re-suspended in 60 |il of ice-cold DEPC-treated water. The size of the RNA probe 
was confirmed by gel electrophoresis and the concentration was determined by 
measuring the optical density at the wavelength of 260 nm. The RNA probe was 
stored at -80°C. 
2.4.2 Fixation and dehydration of embryos 
Mouse and rat embryos were dissected out in ice-cold phosphate 
buffered saline (PBS). Tissues were fixed with 4% paraformaldehyde in 
RNase-free PBS overnight at 4°C overnight. On the following day, embryos were 
washed twice in PBT (PBS with 0.1% Tween-20) for 15 minutes each at 4�C and 
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were then dehydrated with a series of graded methanol in increasing 
concentrations (25%, 50% and 70% in PBT and 100%). Each step took about 15 
minutes at 4°C. Embryos were stored at 20°C. 
2.4.3 Hybridization with RNA probes 
Embryos were rehydrated by passing through decreasing 
concentrations of methanol (75%, 50% and 25% in PBT) for 15 minutes at 4°C in 
each step, followed by washing twice with PBT for 15 minutes in each step. The 
rehydrated embryos were treated with 6% hydrogen peroxide in PBT for 1 hour to 
inactivate the endogenous phosphatase. Embryos were then washed three times 
with PBT for 15 minutes in each step. Embryos were digested in 10 jxg/ml 
proteinase K {Roche) in PBT for about 1-5 minutes depending on the stage of the 
embryo. The duration of proteinase K digestion for mouse embryos at E7, E8 and 
E9 was about 1, 3 and 5 minutes respectively, while that for rat embryos at El 1.5 
was 5 minutes. After that, proteinase K digestion was stopped by washing the 
embryos with 2 mg/ml glycine {BDH) in PBT for 5 minutes. The embryos were 
then washed with PBT for 15 minutes and fixed with 0.2% glutaraldehyde and 4% 
paraformaldehyde in PBT for 20 minutes. After fixation, embryos were washed 
with PBT twice and then pre-hybridized in a pre-warmed pre-hybridization 
solution [50% deionized formamide; 5X SSC (0.75 M NaCl; 0.075 M sodium 
citrate), pH 4.5; 1% sodium dodecyl sulphate (SDS); 50 ^g/ml yeast tRNA 
(Invitrogen); 50 \ig/m\ heparin (Sigma)] for 1.5 hours at 70°C with gentle rocking. 
The pre-hybridization solution was replaced by the pre-warmed hybridization 
solution that contained 1 iiig of DIG-labeled RNA probes in 1 ml of 
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pre-hybridization solution. Hybridization was carried out at 70°C overnight with 
gentle rocking. 
2.4.4 Post-hybridization wash 
RNA probes without binding to the target mRNA were removed by 
washing in solution 1 (50% foraiamide; 5X SSC, pH 4.5; 1% SDS) twice at 70�C 
for 30 minutes in each step. Holes were pinched in the brain of the embryo with a 
tungsten needle to prevent trapping of unbound RNA probes that would result in 
high background staining. After that, embryos were washed with a solution made 
up of 1:1 ratio of solution 1 and solution 2 (0.5 M NaCl; 10 mM Tris-HCl, pH 7.5; 
0.1% Tween-20) for 10 minutes at 70°C, followed by washing with solution 2 for 
three times, each for 10 minutes. Non-specifically bound RNA probes were 
digested away by treating with 100 |ig/ml RNase A {Roche) in solution 2 for 25 
minutes at 37°C. After RNase A digestion, embryos were washed with solution 2 
and then solution 3 (50% formamide; 2X SSC, pH 4.5) for 15 minutes and 5 
minutes respectively. Afterwards, embryos were washed twice with solution 3 for 
30 minutes at 65°C and then three times with TEST [0.14 M NaCl; 2.7 mM KCl; 
25 mM Tris-HCl, pH 9.5; 0.5% Tween-20; 0.5 mg/ml (-)-Tetramisole 
hydrochloride {Sigma)] for 10 minutes each. Embryos were pre-blocked with 10% 
heat-inactivated sheep serum {Jackson ImmunoReasearch) in TEST for 90 
minutes and then incubated overnight at 4°C with pre-absorbed (refer to sections 
2.4.4.1 and 2.4.4.2 for details) alkaline phosphatase-conjugated anti-DIG antibody 
{Roche). 
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2.4.4.1 Pre-absorption of anti-DIG antibody 
Three milligrams of embryo powder (refer to section 2.4.4.2 for details) 
were mixed with TEST and incubated at 70°C for 30 minutes. After incubation, 
the embryo powder was chilled on ice. Sheep serum was heat-inactivated at 56°C 
for 30 minutes and then chilled on ice. Five microlitres of sheep serum and 1 \i\ of 
alkaline phosphatase-conjugated anti-DIG antibody (0.75 units/|il, Roche) were 
added to the embryo powder and then incubated at 4°C for 5 hours. After 
incubation, the embryo powder mixture was centrifuged at 14,000 rpm for 5 
minutes at 4°C. The supernatant was transferred to a new tube and made up to 2 
ml with 1% heat-inactivated sheep serum in TBST. 
2.4.4.2 Embryo powder preparation 
El3.5 mouse embryos were homogenized in PBS by using polytron 
(Sigma). Ice-cold acetone was added to the homogenate and incubated for 30 
minutes on ice. The mixture was then centrifuged at 10,000 rpm for 10 minutes at 
4°C and the pellet was washed with ice-cold acetone. The pellet was air-dried 
thoroughly, grinded into powder and then stored at -20°C. 
2.4.5 Post antibody wash and signal development 
Embryos were washed with TBST three times for 5 minutes each to 
remove the unbound antibody. Any residual antibody was further removed by 
washing the embryos thoroughly with TBST for five times, each for 1 hour. After 
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that, embryos were pre-conditioned in NTMT [100 mM NaCl; 100 mM Tris-HCl, 
pH 9.5; 50 mM MgCl2； 0.1% Tween-20; 0.5 mg/ml (-)-Tetramisole hydrochloride] 
three times for 10 minutes each. 
The signal was developed by applying staining mixture composing of 
22.5 |il of nitro blue tetratzolium {Roche) [75 mg/ml stock in 70% N,N-dimethyl 
formamide {Sigma)'] and 17.5 |LI1 of 5-bromo-4-chloro-3-indolyl phosphate {Roche) 
(50 mg/ml stock in N，N-dimethyl formamide) in 5 ml of NTMT in the dark. When 
an optimal level of signal intensity was reached, the reaction was terminated by 
washing with PBT for three times，each for 10 minutes followed by washing with 
PBS once for 15 minutes. Afterwards, embryos were fixed in 4% 
paraformaldehyde in PBS overnight at 4°C. Embryos were washed with PBS 
twice, followed by clearing with graded glycerol in increasing concentrations 
(50% and 75% in autoclaved milliQ water) thoroughly. Photomicrographs were 
taken by the Leica DFC480 digital camera (Leica) and processed with the Leica 
Application Suite software {Leica). 
2.5 REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION-
POLYMERASE CHAIN REACTION (RT-PCR) 
2.5.1 Sample collection and storage 
Embryos were dissected out in RNase-free ice-cold PBS. After 
removal of excess PBS, the tissue was immediately kept in 10-fold volume of 
RNAlater RNA stabilization reagent (Qiagen) and kept at 4�C overnight. On the 
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following day, the tissue, thoroughly penetrated by the RNA stabilization reagent, 
was stored at -20°C. 
2.5.2 Total RNA extraction 
Total RNA of the sample was extracted by using the Tissue Total RNA 
Mini Kit (Favorgen) according to the manufacturer's protocol. RNA stabilization 
reagent was discarded and the tissue was lysed in 350 |il of FARB lysis buffer 
provided in the kit. The tissue was lysed thoroughly by using a 25G syringe 
needle and the lysate was transferred to a filter column. The filter column with the 
lysate was centrifuged at 14,000 rpm for 1 minute to allow the solution to flow 
through the column. The supernatant was mixed with 350 \i\ of 70% ethanol in 
DEPC-treated water. The mixture was then transferred to a FARB mini column 
and centrifuged at 14,000 rpm for 1 minute. The flow-through was discarded and 
the FARB mini column was kept for further elution. Five hundred microlitres of 
Wash Buffer 1 was added to the FARB mini column and centrifiiged at 14,000 
rpm for 1 minute. Again, the flow-through was discarded and the column was 
washed twice with 700 \i\ of Wash Buffer 2. After that, the flow-through was 
discarded and the column was centrifuged again at 14,000 rpm for 3 minutes to 
dry the column thoroughly. After centrifugation, the column was transferred to a 
new collection tube and 50 \i\ of DEPC-treated water was added to the column. 
After 2 minutes to allow complete penetration, the column was centrifuged at 
14,000 rpm for 2 minutes to elute the total RNA. The concentration of the total 
RNA was determined by measuring the optical density at the wavelength of 260 
nm using a spectrophotometer. The total RNA was stored at -80°C. 
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2.5.3 Reverse transcription 
Total RNA extracted from the tissue was synthesized into cDNA by 
using the High Capacity cDNA Reverse Transcription Kit {Applied Biosystems) 
according to the manufacturer's protocol. Five hundred nanograms of total RNA 
was mixed with the reaction master mix. The master mix for cDNA reverse 
transcription was composed of 1 \i[ of lOX Reverse Transcription Buffer, 0.4 \i[ of 
100 mM dNTP, 1 [xl of lOX Reverse Transcription random primers, 0.5 |LI1 of 
MultiScribe™ Reverse Transcriptase (50 units/|il) and 0.5 |il of RNase Inhibitor 
(20 units/^il). DEPC-treated water was added to the reaction mixture to make up a 
final volume of 10 \x[. Reverse transcription was performed in the CI000 Thermal 
Cycler (BioRad) at 25�C for 10 minutes, followed by 37�C for 120 minutes and 
then 85°C for 5 seconds. The cDNA product was stored at -20°C. 
2.5.4 Quantitative real-time PCR 
The sequences of primers used were listed in sections 3.3.1.3 and 4.3,5. 
The amount of the target genes in the cDNA was quantified by using 
the ABI 7500 Fast Real-Time PCR system {Applied Biosystems). Various pairs of 
primers for target genes were used for PCR amplification. The concentration of 
cDNA was diluted 10-fold or 20-fold with DEPC-treated water prior to 
amplification. The reaction mixture for each well was composed of 1 |il of diluted 
cDNA, 0.125 |il each of 400 \iM forward and reverse primers, 2.5 jil of 2X 
POWER SYBR® Green PCR Master Mix {BioRad) and 1.25 |il of DEPC-treated 
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water to make up to a final volume of 5 [xl A set of standards with known 
concentrations of the target gene (refer to section 2.5.5 for details) was applied to 
measure the quantity of the product being amplified. Each sample or standard was 
amplified in triplicate to ensure the validity of amplification. 
The thermal conditions started at 95°C for 10 minutes to initiate the 
PGR. It was followed by denaturing at 95°C for 15 seconds and annealing at 55°C 
for 1 minute for 40 cycles. The quantity of the target gene was analyzed by the 
ABI Prism® 7000 SDS software {Applied Biosystems). 
2.5.5 Preparation of cDNA standards for real-time PCR 
The cDNA standards were generated by PCR amplification of serially 
diluted cDNA plasmids of the target gene with known concentrations. The cDNA 
plasmids of the target genes for making the standards were synthesized as 
described in section 2.4.1.1 and 2.4.1.2 叫d the concentration was determined by 
measuring the optical density at the wavelength of 260 nm using a 
spectrophotometer. The cDNA plasmids were subjected to 10-fold serial dilution 
to obtain a set of standards ranging from 0.02 pg to 20 pg. 
2.6 RA-RESPONSIVE CELL LINE 
The RA-responsive cell line (a gift from Prof. Peter McCaffery) is 
derived from the F9 teratocarcinoma cell line, which is stably transfected with 
DNA sequences containing the RARp gene that possesses a RARE at the promoter 
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region and the j3-galactosidase gene as the reporter. The expression of 
P-galactosidase is driven by the activation of the RARE in the presence of RA 
(McCaffery and Drager, 1997; Wagner, 1998). The expression level of 
P-galactosidase is directly and linearly proportional to the log RA concentration 
in the range oflO'^^M to lO'^ M. 
2.6.1 Cell culture 
The RA-responsive cells were stored frozen in sealed plastic ampule in 
liquid nitrogen. The cells were thawed as quickly as possible in a water bath at 
37�C. When the cells were completely thawed, the ampule was sterilized by 70% 
ethanol and cut open with a sterilized knife. The cells were pipetted out and 
diluted with 10 ml of Hank's medium {Gibed) to minimize the toxicity of 
dimethyl sulfoxide (DMSO) in the freezing medium. The cells were centrifuged at 
3,000 rpm for 3 minutes. The cell pellet was then re-suspended in 5 ml of culture 
medium. The culture medium was composed of Dulbecco's Modified Eagle's 
Medium (DMEM, Gibed) supplemented with 10% fetal bovine serum {Gibco\ 2 
mg/ml G418 {Sigma\ 100 units/ml penicillin G {Sigma) and 0.1 mg/ml 
streptomycin (Sigma). The cells were grown in a 25 cm^ culture flask (Coming), 
which had been pre-coated with 0.1% gelatin solution for 30 minutes, in a 5% 
CO2 incubator at 37°C until the cells reached 70-80% confluence, which usually 
took about 2 days. 
To subculture the cells, 3 ml of 0.25% trypsin {Gibed) in Hank's 
medium was pipetted into the flask and the cells were incubated at 37°C for 1-2 
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minutes. When the cells have detached from the surface, 10 ml of culture medium 
was added to stop the reaction. The cell suspension was centrifuged at 3,000 rpm 
for 3 minutes. The cell pellet was re-suspended in 5 ml of culture medium for 
further subculture or seeding onto the 96-well plate. 
2.6.2 Seeding 96-well plate with RA-responsive cells 
To transfer RA-responsive cells from the culture flask to a 96-well 
plate, cells in the culture flask were first detached by 3 ml of 0.25% trypsin. About 
5 ml of culture medium was pipetted into the cell suspension to stop the reaction 
of trypsin. The cell suspension was then pipetted up and down to break apart the 
cell clusters. The cell density of the cell suspension was evaluated by counting the 
number of cells using a hematocytometer. The cell suspension was centrifiiged at 
1,500 rpm for 3 minutes. The cell pellet was re-suspended in the culture medium 
at a cell density of 2 x 10^  cells per ml. The cell suspension, at a volume of 100 |il, 
was pipetted into each well in a 96-well plate that had been pre-coated with 0.1% 
gelatin solution for 30 minutes. It took about 16 hours for the cells to grow up to 
80% confluence in a 5% CO2 incubator at 37°C. 
2.6.3 Applying samples to 96-well plate coated with RA-responsive cells 
19 
The RA detection limit of this RA-responsive cell line is between 10' 
M to 10-7 M. RA standard solutions were first prepared by 10-fold serial dilution 
of RA in DMSO down to 10"^  M. The RA solution was further subjected to 
10-fold serial dilution down to M with the culture medium instead of DMSO 
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in order to minimize the toxicity ofDMSO. RA standard solutions from M to 
10-7 M and the RA-containing samples, at a volume of 100 |il, were applied in 
triplicate to the 96-well plate that had been coated with RA-responsive cells. The 
plate was incubated in a 5% CO2 incubator at 37�C for approximately 16 hours. 
2.6.4 P-galactosidase staining 
. T h e expression level of the p-galactosidase enzyme was quantified by 
detecting its ability to change the substrate 5-bromo-4-chloro-3-idolyl-p-galacto-
pyranoside (X-gal, Gibco) into a color product. First, the RA-containing medium 
was discarded and the cells were fixed with 100 |xl of 1% glutaraldehyde in PBS 
for 10 minutes. After fixation, the plate was washed with PBS for 3 times. 
Staining solution [1 mg/ml X-gal dissolved in dimethyl foraiamide; 3.3 mM 
K4Fe(CN)6. 3H2O; 3.3 mM K3Fe(CN)6. SHjO; 6 mM MgCb in PBS], at a volume 
of 100 \i\, was applied to each well and was incubated for 2 hours at 37�C. After 
that, the staining solution was discarded and the plate was washed with 100 |il of 
PBS for 3 times. The expression level of the P-galactosidase reporter gene was 
quantified by measuring the colorimetric readings at the wavelength of 650 nm 
using an ELISA plate spectrophotometer (Benchmark, BioRad). The stained 
96-well plate could be stored in 75% glycerol at 4�C. 
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2.7 SEPARATION OF PROTEIN ISOFORMS BY ISOELECTRIC 
FOCUSING (LEF) 
2.7.1 Preparing protein samples for lEF 
Total protein from the whole embryo was used for lEF processing. 
First, samples were defrosted from -80°C and then lysed in 100 |il of ice-cold 
autoclaved water with 0.6 mg/ml dithiothreitol (DTT，Sigma) by sonication. The 
homogenate was then centrifuged at 12,000 rpm for 10 minutes at 4°C to remove 
large debris. The supernatant was collected. Protease inhibitor cocktail (cat no. 
P8340, Sigma) was added at a volume of 1% into the lysate to prevent protein 
degradation. The protein concentration of the lysate was then measured by 
Bradford protein assay. Two microliters of protein lysate was diluted in 798 |il of 
autoclaved milliQ water and mixed with 200 \x\ of protein assay dye reagent 
concentrate (BioRad). After 10 minutes, the signal was measured at the 
wavelength of 595 nm using a spectrophotometer. The standard of this assay was 
set up by known concentrations of bovine serum albumin. 
2.7.2 Isoelectric focusing 
The lEF native gel was freshly prepared prior to lEF. The dry 
polyacrylamide gel (GE Healthcare) was immersed evenly in 11 ml of ampholyte 
mixture composing of 7.5% pharmalyte (pi range 3.5-9.5, GE Healthcare), 1.1 g 
D-sorbitol and 0.6 mg/ml DTT in autoclaved milliQ water for 45 minutes. When 
the lEF native gel was ready for lEF, it was subjected to pre-focusing by running 
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in a Multiphor II Electrophoresis System {GE Healthcare) set at 700 V，12 mA, 8 
W for 20 minutes at 10�C to relocate the ions to the appropriate locations 
throughout the gel. When pre-focusing was completed, 20 |il of a protein marker 
(cat no. 17-0471-01，GE Healthcare) containing a combination of proteins with 
known pi and 80 \ig of protein samples were loaded onto loading papers near the 
cathode on the gel. To allow the samples entering the gel slowly, a low voltage 
(500 V, 8 mA, 8 W) was first applied for 20 minutes. After that, a high voltage 
(2,000 V，14 mA, 14 W) was applied for 90 minutes to separate the proteins. At 
the end of the focusing, proteins with different isoelectric points would be 
separated accordingly and then an even higher voltage (2,500 V, 14 mA, 18 W) 
was applied to sharpen the band, resulting in a clear distinction between proteins 
with different isoelectric points. Isoelectric focusing was conducted at 10°C to 
prevent denaturation of the protein. 
2.7.3 lEF native gel staining 
The portion of the gel containing the protein markers was cut out and 
fixed immediately in 20 ml of fixative solution [11.6% trichloroacetic acid 
{Sigma); 3.4% 5-sulphosalicylic acid (Sigma) in autoclaved milliQ water] for 30 
minutes. After fixation，the marker gel was washed with 50 ml of destaining 
solution (25% absolute ethanol; 8% acetic acid in autoclaved milliQ water) twice 
for 10 minutes each and stained with 20 ml of 0.1% Coomassie PhastGel Blue 
R-350 (GE Healthcare) in destaining solution for 5-10 minutes at 60°C until the 
bands were clearly stained. After that, the marker gel was washed with destaining 
solution again until the background was clear. 
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2.7.4 Locating three retinaldehyde dehydrogenase (Raldh) isoforms 
When a mixture of proteins is applied to certain position in the 
pre-focused lEF native gel with a pH gradient, proteins with a higher pi value will 
be positively charged and migrate to the cathode. In contrast, proteins with a 
lower pi value will be negatively charged and migrated to the anode. When a 
protein migrates to the point where the pH value is equivalent to its pi value, the 
protein will have zero net charge. lEF is an end point method meaning that 
proteins are stable without time-limit when they reach their isoelectric points. The 
relative migration distance of the protein from the cathode is inversely 
proportional to the pH value of the protein, which means the lower the pH, the 
longer the travel distance of the protein. Besides that, the relative migration 
distance and the pH value of the protein show a linear relationship. Based on these 
characteristics, the travel distance of the bands of the protein markers was 
measured and was plotted into a linear trendline corresponding to their pi values. 
By using the equation of the trendline, the travel distance of any protein with 
known pi value can be calculated and the protein of interest can be precisely 
located in the gel. 
The range of pi values of the 3 Raldh isoforms, Raldhl, Raldh2 and 
Raldh3 are 6.5-6.9, 4.9-5.4 and 6.0-6.3 respectively (Mey et al, 2001). By using 
the equation of the trendline, the regions in the gel that contained the 3 Raldh 
isoforms were identified. Since the pi range of the 3 isoforms does not overlap, 
the 3 non-overlapping gel portions were cut out on ice. 
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2.8 IN VITRO R A SYNTHESIZING REACTION 
The gel portion was immediately immersed in 200 of RA 
synthesizing reaction mixture containing 50 nM 2X\-trans retinal {Sigma), 0.8 
mg/ml nicotinamide adenine dinucleotide (NAD), 0.6 mg/ml DTT and 100 nM 
Cyp26 inhibitor R115866 (Stoppie et al., 2000，a gift ^om Johnson and Johnson) 
in DMEM. Apart from the samples, a blank without any sample, a positive control 
and a negative control were included in each set of experiment. The positive 
control contained equivalent amount of protein homogenate (80 |ig) from the 
control group without lEF processing, whereas sample containing equivalent 
amount of protein homogenate from the control group without lEF processing 
added with 0.95% citral {Sigma) in DMEM served as the negative control. Citral 
is a RA synthesizing enzyme inhibitor that can inhibit both retinol dehydrogenases 
and retinal dehydrogenases (Raner et al, 1996; Kikonyogo et al., 1999). However, 
since only retinal was added into the reaction mixture, the addition of citral could 
show that RA was indeed synthesized by Raldh enzyme in the sample. All 
reactions were added with 100 nM Cyp26 inhibitor to inhibit any RA degrading 
activity, thereby maximizing RA synthesis. The reaction tube was wrapped with 
aluminum foil since RA is light-sensitive and then incubated for 2 hours at 37 
At the end of incubation, the reaction mixture was diluted 20-fold with the culture 
medium to reduce the toxicity of NAD and DTT. One hundred micro litres of the 
diluted reaction mixture was added to each well of RA-responsive cells. Each 
sample was applied in triplicate. The amount of RA being synthesized was 
quantified by using the RA-responsive cells as indicated in sections 2.6.3 and 
2.6.4. 
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3.1 INTRODUCTION 
There are growing evidences that there is a reduction in the plasma 
vitamin A and retinol binding protein levels in human diabetic patients (Basu and 
Basualdo, 1997; Olmedilla et al, 1997; Granado et al” 1998; Baena et al., 2002) 
and in streptozotocin-induced diabetic rats (Tuitoek et al., 1996a,b). Vitamin A 
obtained from maternal circulation is an important precursor for RA synthesis in 
the embryo. Hence, a lowering in maternal vitamin A levels may lead to reduced 
RA synthesis in the embryo. 
RA synthesis is tightly regulated by the RA synthesizing enzyme 
retinaldehyde dehydrogenase (Raldh), which has three isoforms named as Raldhl, 
Raldh2 and RaldhS. In the mouse embryo, expression of Raldhl is initiated at 
mid-gestation and is limited to the dorsal optic vesicle (Suzuki et al., 2000). 
However, at later stages during fetal development, Raldhl expression is found in 
many organs such as the lung, stomach, kidneys and heart (Niederreither et al., 
2002a). As for Raldh2, expression is initiated during gastrulation in the mesoderm 
adjacent to the node and primitive streak. At mid-gestation, Raldh2 is expressed in 
periocular region, in the somites, along the lateral walls of the intraembryonic 
coelom, and around the hindgut diverticulum (Niederreither et al., 1997). Later, it 
is expressed in various differentiating organs including the heart, kidneys and 
lungs (Moss et al., 1998; Niederreither et al., 2002a). Raldh3 expression is first 
detectable in the prospective eye field of early somite-stage mouse embryo 
(Suzuki et al., 2000) and then becomes restricted to the ventral retina (McCaffery 
et al., 1999). It is also expressed in the otic vesicle, olfactory pit and ventral 
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forebrain (Li et al., 2000; Mic et al., 2000). Similar to Raldhl and Raldh2, RaldhS 
is ftirther expressed in a number of differentiating organs such as the kidney at 
later stages (Niederreither et al., 2002a). 
Among the three isoforais, Raldh2 is the dominant one. The majority 
of RA is synthesized by Raldh2 during early embryonic development 
(Niederreither et al., 1997; 2002b). It has been reported that Raldh2{-/-) mouse 
embryos die during mid-gestation as a result of impaired heart looping and 
myocardial differentiation (Niederreither et al., 1999; 2001). Other than that, 
abnormal hindbrain patterning (Niederreither et al., 2000) and A-P patterning 
(Niederreither et al., 2002c), absence of branchial arches (Niederreither et al., 
2003), and asymmetric and compacted somite formation are also found (Vermont 
et al., 2005). 
RA levels in the embryo are tightly controlled by the opposing action 
of the RA synthesizing and catabolizing enzymes, which express in 
complementary non-overlapping domains in the embryo (Swindell et al., 1999). 
RA is catabolically inactivated by Cyp26 that has 3 isoforms, Cyp26al, bl and CI 
(Fuji et al., 1997; MacLean et al., 2001; Tahayato et al., 2003)，among which 
Cyp26al is the dominant one. Similar to disruption of RA synthesis, disruption of 
RA catabolism can lead to embryonic lethality. Cyp26al{-I-) mouse embryos die 
at mid-late gestation, with severe truncation of the caudal region and abnormal 
patterning of the hindbrain (Abu-Abed et al., 2001; Sakai et al., 2001). Recently, 
our laboratory has found that there is a significant down-regulated expression of 
Cyp26al in the mouse embryo of diabetic pregnancy, which increases the risk of 
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the embryo in developing different kinds of congenital malformations (Lee, 2007). 
However, the mechanism that underlies the down-regulation of Cyp26al 
expression remains to be determined. In the promoter region of Cyp26al, more 
than one RARE have been identified (Loudig et al., 2000; 2005). Thus, the 
expression of Cyp26al can be directly regulated by RA. This leads to our 
speculation that down-regulation of Cyp26al expression might be caused by a 
reduction in RA synthesis in the embryo. 
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3.2 EXPERIMENTAL DESIGN 
The aim of this chapter was to examine whether there was any 
significant difference in RA synthesis in embryos of diabetic and non-diabetic 
mice. RA synthesis was determined by two parameters: the mRNA expression 
level of Raldh genes and the in vitro RA synthesizing activity of Raldh enzymes. 
To achieve this, first, the expression of the mRNA transcripts of the three iso forms 
of Raldh {Raldhl, Raldh2 and Raldh3) in embryos of diabetic and non-diabetic 
mice during early post-implantation development, from primitive streak stage (E7) 
to mid-gestation (E9), was examined qualitatively by whole mount in situ 
hybridization. This could determine whether any changes in the expression of 
these genes were tissue-specific or generally occurred in all expression domains. 
This was followed by quantification of the mRNA expression level using 
real-time RT-PCR. Next, the RA synthesizing activity of Raldh enzymes in 
embryos of diabetic and non-diabetic mice at these stages was determined by an 
in vitro assay. To begin with, the 3 iso forms of Raldh were separated by isoelectric 
focusing (lEF). The activity of each enzyme was then determined by its ability to 
convert the substrate dXX-trans retinal into RA under in vitro conditions. The 
amount of RA was then measured by using a RA-responsive cell line (McCaffery 
and Drager, 1997; Wagner, 1998). 
• . 
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3.3 MATERIALS AND METHODS 
3.3.1 Sample collection 
3.3.1.1 Criteria for selecting embryos at the same developmental stage 
Since embryos develop very quickly during the early period of 
organogenesis and embryos within the same litter may develop at different rates, it 
is important that embryos at the same developmental stage are collected for 
comparison. To evaluate the developmental stage of the embryo at the early stage 
of organogenesis, the number of somites is a good indicator of developmental 
stage. Apart from somite number, various morphological structures are also good 
landmarks for identifying the stage of the embryo, particularly when somites have 
not yet formed (Downs and Davies, 1993). Embryos at the primitive streak stage 
(not yet reaching headfold stage) were collected as E7 embryos. Embryos with 
8-10 and 19-20 pairs of somites were collected as E8 and E9 embryos 
respectively. 
3.3.1.2 Sample collection for in situ hybridization 
Pregnancies were obtained by mating between diabetic and 
non-diabetic ICR female mice with ICR male mice. Prior to sacrifice for embryo 
collection, blood glucose level of the diabetic mouse was measured by \ising a 
glucometer to confirm that the mouse was indeed diabetic. Around 5:00 pm on E7, 
12:00 pm on E8 and E9, embryos were dissected out from the uterus in ice-cold 
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DEPC-treated PBS. Embryos were processed for analysis of Raldhl, Raldh2 and 
Raldh3 mRNA expressions by in situ hybridization using RNA probes prepared 
from the following cDNA plasmids and protocols as described in section 2.4. 
Raldhl and RaldhS mouse cDNA plasmids were gifts from Prof. Ursula Drager, 
whereas Raldh2 mouse cDNA plasmid was a gift from Prof. Peter McCaffery. 
Between 3 to 6 litters of embryos were examined for each group. 
Particulars of cDNA plasmids: 
Restriction RNA polymerase cDNA Insert size enzyme for Vector for antisense plasmid (bp) antisense riboprobe riboprobe 
Raldhl pBluescript KS 400 Not I T3 
Raldhl pBluescript KS 2,300 Xbal T7 
Raldh3 pCR®II-TOPO 800 Not I Sp6 
3.3.1.3 Sample collection for real-time quantitative RT-PCR 
Embryos of diabetic and non-diabetic mice were dissected out on E7, 
E8 or E9 and selected using the criteria as described in section 3.3.1.1. For E7 
embryos, the ectoplacental cone was removed and the whole embryo was 
collected. For E8 and E9 embryos, they were freed from the yolk sac and amnion, 
and only the embryo proper was collected. Selected embryos at the specified 
developmental stage from the same litter were pooled as one sample. Embryos 
were subjected to quantification of Raldhl, Raldh2 and RaldhS mRNA expression 
levels by real-time RT-PCR using primers as detailed below and protocols as 
described in section 2.5. The mouse housekeeping gene P-actin, with primer 
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sequences as detailed below, was used as the internal control for normalization of 
PGR products in each sample. The PGR products amplified were: a 172 bp 
sequence corresponding to nucleotide sequences 885-904 and 1056-1037 of 
mouse Raldhl, a 201 bp sequence corresponding to nucleotide sequences 945-964 
and 1145-1126 of mouse Raldhl, a 196 bp sequence corresponding to nucleotide 
sequences 2872-2891 and 3067-3048 of mouse RaldhS, a 165 bp sequence 
corresponding to nucleotide sequences 304-323 and 468-449 of mouse p-actin. 
Between 5 to 6 samples were examined for each group. 
Sequences of primers: 
Mouse Raldhl forward primer: 5'-CAT TGC TGT TGA GTT TGC AC-3’ 
reverse primer: 5，-TTG ATT TAT TCC TGG GGT CA-3， 
Mouse Raldhl forward primer: 5，-TTG CAG ATG CTG ACT TGG AC-3 ’ 
reverse primer: 5 ,-TCT GAG GAC CCT GCT CAG TT-3, 
Mouse RaldhS forward primer: 5'-GAT AAA GTT GGG CTG AGC AA-3' 
reverse primer: 5’-CCA AAATTC AGT GTC CGA AG-3, 
Mouse P-actin forward primer: 5'-TGT TAG CAA CTG GGA CGA CA-3， 
reverse primer: 5,-GGG GTG TTG AAG GTC TCA AA-3, 
3.3.1.4 Sample collection for in vitro RA synthesizing reaction 
Embryos of diabetic and non-diabetic mice were dissected out on E8 
or E9 and selected according to the criteria as described in section 3.3.1.1. 
Selected embryos at the desired developmental stage from the same litter were 
pooled as one sample. The sample was subjected to separation of the three 
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isoforms of Raldh enzymes by lEF as described in section 2.7. Sample of the 
non-diabetic group without lEF processing and added with the RA synthesizing 
enzyme inhibitor citral served as a negative control. The RA synthesizing activity 
was measured by an in vitro assay as described in section 2.8. The amount of RA 
being synthesized was quantified by using the RA-responsive cell line as 
described in section 2.6. The RA synthesizing activity is defined as the 
concentration of RA in nM synthesized by 1 of embryo protein lysate applied 
to lER Five samples were analyzed for each group. 
3.3.2 Statistical analyses 
Analyses of the mRNA expression level of RaldhI, RaldhI and RaldhS, 
and the in vitro RA synthesizing activity of Raldh2 enzymes between embryos of 
diabetic and non-diabetic mice were conducted by Independent Samples t-test. All 
statistical analyses were performed using SPSS software (SPSS), with statistical 
significance level set at/? < 0.05. 
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3.4 RESULTS 
3.4.1 Comparison of the in situ expression pattern of Raldhl, Raldh2 and 
RaldhS between embryos of diabetic and non-diabetic mice 
3.4.1.1 In situ hybridization patterns of Raldhl 
At mid-gestation (E9), Raldhl expression was only observed in the 
dorsal optic vesicle of mouse embryos of non-diabetic mice (Figure 3.1 A). The 
expression level of Raldhl in this region was prominently reduced in embryos of 
diabetic mice (Figure 3.IB). 
3.4.1.2 In situ hybridization patterns of Raldhl 
Figure 3.2 showed that Raldhl had much broader expression domains 
than Raldhl. In primitive streak stage mouse embryos of non-diabetic mice on E7, 
Raldh2 was expressed at high levels in the embryonic mesoderm lateral to the 
primitive streak (Figure 3.2A), whereas the expression level of Raldh2 was 
dramatically reduced in the diabetic group (Figure 3.2B). As development 
proceeded to early somite-stage on E8, Raldh2 was expressed in the cranial and 
trunk regions (Figure 3.2C). The expression level of Raldh2 was prominently 
reduced in the cephalic neural fold of the prospective forebrain and the somitic 
mesoderm in embryos of diabetic mice (Figure 3.2D) in comparison to embryos 
of non-diabetic mice (Figure 3.2C). In mid-gestation stage mouse embryos on E9, 
Raldh2 was expressed at low levels in the region between the optic eminence and 
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first branchial arch, and also at high levels in the somites and pre-somitic 
mesoderm, in a lateral domain corresponding to cells along the dorso-lateral edges 
of the coelomic cavity, and in the hindgut diverticulum towards the base of the 
allantois (Figue 3.2E). In embryos of diabetic mice, expression of Raldh2 in the 
region between the optic eminence and first branchial arch was almost lost and the 
expression level in all other domains was prominently reduced (Figure 3.2F). 
3.4.1.3 In situ hybridization patterns of RaldhS 
At mid-gestation (E9)，RaldhS was expressed strongly in the optic and 
frontonasal regions of embryos of non-diabetic mice (Figure 3.3 A). However, the 
expression level of RaldhS in these regions was prominently reduced in embryos 
of diabetic mice (Figure 3.3B). 
Results of in situ hybridization studies showed that there were 
observable differences in the expression level of Raldhl, Raldhl and RaldhS 
between embryos of diabetic and non-diabetic mice. To quantitatively compare 
the expression level between the two groups of embryos, real-time RT-PCR was 
conducted, with results presented in the following section. 
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3.4.2 Comparison of the relative expression level of Raldhl, Raldhl and 
RaldhS between embryos of diabetic and non-diabetic mice at 
different developmental stages 
The relative expression level of Raldhl, Raldhl and RaldhS in embryos 
of diabetic and non-diabetic mice at different developmental stages and results of 
statistical analyses were summarized in Tables 3.1, 3.2 and 3.3, and presented in 
Graphs 3.1，3.2 and 3.3 respectively. 
Table 3.1 Relative expression levels of Raldhl in embryos of diabetic (SD) and 
non-diabetic (ND) mice at different developmental stages. 
Developmental stage E7 E8 E9 
No. of litters in ND group 6 6 5 
No. of litters in SD group 6 5 5 
Expression levels of „ . . 0.00043 0.00104 0.00340 Raldhl!B-actin in ND ± 2.72E-05 ± 1.30E-04 ± 2.70E-04 
group 土 SEM 
Expression levels of « … • • on 0.00028 0.00060 0.00170 Raldhl!B-actin in SD R^r.^；, 士 5.:37E-05 士 1.34E-04 士 l.lOE-04 group 土 SEM o-value of ND vs. SD <0.05* < 0.05* <0.001* group 
% difference of SD from �Tn -34% -42% -50% ND group 
* Statistically significant (Independent Samples t-test) 
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Table 3.2 Relative expression levels of Raldh2 in embryos of diabetic (SD) and 
non-diabetic (ND) mice at different developmental stages. 
Developmental stage E7 £8 E9 
No. of litters in ND group 5 6 5 
No. of Utters in SD group 5 6 5 
Expression levels of 
� 0.088 1.510 1.180 
士 0.027 ±0.033 ± 0.046 
group 土 SEM 
Expression levels of 0.021 1.270 1.000 Raldh2/6-actin in SD j T c r u 士 0.007 士 0.033 士 0.043 group 土 SEM p-value of ND vs. SD < 0.05* <0.001* < 0.05* group % difference of SD from �Tn -76% -16% -15% ND group 
* Statistically significant (Independent Samples t-test) 
Table 3.3 Relative expression levels of RaldhS in embryos of diabetic (SD) and 
non-diabetic (ND) mice at different developmental stages. 
Developmental stage E7 E8 E9 
No. of litters in ND group 6 5 5 
No. of litters in SD group 6 5 5 
Expression levels of n . . � T 0.0024 0.0073 0.0280 Raldh3ffi~actin inND 
±1.6E-04 士 0.001 士 3.5E-03 
group 土 SEM 
Expression levels of n L • . … 0.0026 0.0040 0.0150 RaldhS!^actin in SD R^r?^^ 土 3.0E-04 ±6.0E-04 ±7.1E-04 group 土 SEM D-value of ND vs. SD 0.73 < 0.05* < 0.05* group . % difference of SD from �Tn +5% -45% -46% ND group 
* Statistically significant (Independent Samples t-test) 
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3.4.2.1 Relative expression levels of Raldhl 
On E7, the relative expression level of Raldhl in embryos of diabetic 
mice was significantly down-regulated by 34% when compared with the 
non-diabetic group (Table 3.1，Graph 3.1). On E8, the significant difference in 
Raldhl expression levels between the two groups increased to 42% and then 
further significantly increased to 50% on E9. The expression level of Raldhl 
relative to p-actin was very low. Although the expression level increased 
progressively from E7 to E9 as the embryos developed during early organogenesis, 
the expression level of Raldhl was still several hundreds fold lower than Raldh2 
(Table 3.2，Graph 3.2), which agreed with the limited small expression domain of 
Raldhl in the embryo (Figure 3.1). 
3.4.2.2 Relative expression levels of Raldhl 
On E7, when Raldh2 expression was first initiated in the embryo, the 
relative expression level of Raldhl in embryos of diabetic mice was significantly 
less than the non-diabetic group by 76% (Table 3.2, Graph 3.2). On E8 and E9, 
although the relative expression level of Raldh2 was still significantly 
down-regulated in the diabetic group, the difference between the diabetic and 
non-diabetic groups was reduced to 15-16%. From E7 to E8, the expression level 
of Raldh2 increased by over 17-fold in the non-diabetic group and over 60-fold in 
the diabetic group. At all developmental stages studied, the relative expression 
level of Raldh2 was very much higher that that of Raldhl (Table 3.1，Graph 3.1) 
and RaldhS (Table 3.3, Graph 3.3), which agreed with the broad expression 
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domains of RaldhI in the embryo (Figure 3.2)，showing that Raldh2 is the 
dominant isoform in the embryo. 
3.4.2.3 Relative expression levels of Raldh3 
On E7, the relative expression level of RaldhS was very low and there 
was no significant difference between embryos of diabetic and non-diabetic mice 
(Table 3.3, Graph 3.3). However, on E8, the relative expression level of RaldhS 
was significantly down-regulated by 45% in the diabetic group when compared 
with the non-diabetic group. Similar extent of down-regulation (46%) was found 
in embryos of diabetic mice on E9. From E7 to E9, although the expression level 
of RaldhS increased progressively as the embryos developed during early 
organogenesis, it was still much lower than Raldh2 (Table 3.2, Graph 3.2), but 
higher than RaldhI (Table 3.1, Graph 3.1), which agreed with the restricted 
expression domain of RaldhS in the embryo (Figure 3.3). 
After confirming that there were significant down-regulation oiRaldhI, 
Raldh2 and RaldhS mRNA expressions in embryos of diabetic mice at different 
developmental stages when compared with embryos of non-diabetic mice, 
experiments were conducted to determine if there was any corresponding 
reduction in the in vitro RA synthesizing activity in the diabetic group, with 
results presented in the following section. 
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3.4.3 Comparison of the in vitro RA synthesizing activity of Raldhl, 
Raldh2 and Raldh3 enzymes between embryos of diabetic and 
non-diabetic mice at different developmental stages 
In the preliminary experiment, it was found that the in vitro RA 
synthesizing activity of Raldh enzymes in E7 embryos of non-diabetic mice was 
undetectable by our bio assay system. It was probably because the protein 
concentration of Raldh enzymes in E7 embryo was too low to synthesize 
sufficient amount of RA within the sensitivity range of the RA-responsive cell line. 
Corresponding with low mRNA expression levels of Raldhl and RaldhS, the in 
vitro RA synthesizing activity of both Raldhl and RaldhS enzymes in E8 and E9 
embryos of diabetic and non-diabetic mice was below the detection limit of our 
bioassay system. Only the in vitro RA synthesizing activity of Raldh2 enzymes 
was detectable in embryos of diabetic and non-diabetic groups, with results 
summarized in Table 3.4 and presented in Figure 3.4. 
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Table 3.4 In vitro RA synthesizing activity of Raldh2 in embryos of diabetic (SD) 
and non-diabetic (ND) mice at different developmental stages. 
Developmental stage E8 E9 
Sample size of ND group 5 5 
Sample size of SD group 5 5 
Sample size of ND group ^ ^ 
added with citral 
Amount of RA synthesized by X o ^ L 0.267 0.137 ND group 土 SEM … ±0.027 士 0.01 (nM per jig protein) 
Amount of RA synthesized by on .。丄 0.147 0.092 SD group 土 SEM , . 、 士 0.028 士 0.009 (nM per fig protein) 
Amount of RA synthesized by 
ND group added with citral 土 „ , Undetectable Undetectable SEM 
(nM per fig protein) 
/7-value of ND vs. SD group < 0.05* <0.01* 
% difference in SD group -45% -33% 
* Statistically significant (Independent Samples t-test) 
The in vitro RA synthesizing activity of Raldh2 enzymes, measured in 
terms of the amount of RA being synthesized in vitro from the precursor dl\-tmns 
retinal, in E8 embryos of diabetic mice was 45% lower than embryos of 
non-diabetic mice (Table 3.4, Graph 3.4). On E9, the significant difference in the 
in vitro RA synthesizing activity of Raldh2 enzyme between the non-diabetic and 
diabetic groups was reduced to 33%. As a negative control，citral, an inhibitor of 
the RA synthesizing enzyme, was added in the medium containing the same 
amount of protein lysate of the non-diabetic group. Results showed that no RA 
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was detected in this control group, confirming that RA was synthesized by RA 
synthesizing enzymes present in the protein lysate of the sample. 
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3.5 DISCUSSION 
Results of in situ hybridization studies clearly showed that the 
expression levels of Raldhl, Raldhl and RaldhS were reduced in the mouse 
embryo of diabetic pregnancy. Moreover, prominent reduction was observed in all 
expression domains, indicating that the down-regulation of the three isoforms of 
Raldh is not limited to certain tissues only, although some regions may have a 
greater extent of reduction than others. 
Expression of Raldhl is first initiated in the mouse embryo at primitive 
streak stage (Niederreither et al., 1997). Results from real-time quantitative 
RT-PCR studies showed that there was a significantly lower level of Raldhl and 
Raldh2 expression in the primitive stage mouse embryos of diabetic mice on E7, 
in particular, Raldh2 expression was 76% less than that of the non-diabetic group, 
suggesting that maternal diabetes severely suppresses the induction of RA 
synthesizing genes. As development proceeded to E8 and E9, the expression level 
of Raldhl, Raldh2 and RaldhS was still significantly lower in embryos of diabetic 
mice, which implies that these genes are continuously being down-regulated 
during early organogenesis. However, the extent of reduction of Raldh2 at these 
stages was much less (15-16%) than at the primitive streak stage (76%). 
Among the three Raldh isoforms, Raldh2 is the dominant one for RA 
synthesis in the embryo (Niederreither et al, 2002b) and is indispensable for 
embryo development (Niederreither et al., 1999). Results of this chapter also 
agree with this because in vitro RA synthesizing activity was only detectable for 
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Raldh2, but not Raldhl and RaldhS enzymes. Moreover, results showed that 
concomitant with a significant reduction in the mRNA expression level of Raldh2, 
the in vitro RA synthesizing activity of Raldh2 enzymes in E8 and E9 embryos of 
diabetic mice was also significantly reduced. Together, these findings support that 
RA synthesis is reduced in embryos of diabetic mice, which will result in a lower 
endogenous level of RA. 
Although the gene expression level of Raldh2 was down-regulated by 
15-16% in E8 and E9 embryos of diabetic mice, the in vitro RA synthesizing 
activity of Raldh2 enzymes was reduced by 45% and 33% respectively. These 
findings indicate that the extent of reduction in Raldh2 gene level does not 
linearly correspond with the extent of reduction in the in vitro RA synthesizing 
activity of Raldh2 enzyme. The reduced amount of RA being synthesized in the in 
vitro assay may be caused by a reduction in the enzymatic activity and/or a 
reduction in the amount of Raldh2 protein. Thus, it remains to be determined 
whether maternal diabetes, other than affecting the transcription of Raldhl, may 
also directly affect the translation and/or the enzymatic activity ofRaldh2. 
Taken together, results of this chapter support that RA synthesis is 
reduced in embryos of diabetic mice, as there are significantly lower levels of 
both the gene expression of Raldhl, Raldh2 and RaldhS, and the in vitro RA 
synthesizing activity of Raldh2 enzymes at early to mid-gestation. However, what 
is the underlying mechanism for reducing RA synthesis in embryos of diabetic 
pregnancy? In the diabetic milieu, many factors are altered. It has been shown that 
elevated glucose is an important factor that increases the risk of malformation. 
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Thus, in the next chapter, a series of experiments was conducted to determine 
whether elevated glucose could reduce RA synthesis. 
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Figure 3.1 In situ hybridization patterns of RaldhI in E9 embryos of 
diabetic and non-diabetic mice. 
A. Expression of RaldhI was restricted to the dorsal optic vesicle (arrowhead) 
in embryos of non-diabetic mice (ND). 
B. There was prominent reduction of RaldhI expression in the dorsal optic 
vesicle in embryos of diabetic mice (SD). 
Label: Arrowhead, dorsal optic vesicle 
Scale bar: A and B, 0.5 mm 
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Figure 3.2 In situ hybridization patterns of Raldhl in embryos of diabetic 
and non-diabetic mice at different developmental stages. 
A. In primitive streak stage embryos of non-diabetic mice (ND) on E7，Raldhl 
was strongly expressed in the embryonic mesoderm (broken circle). 
B. There was a dramatic reduction of Raldh2 expression in the embryonic 
mesoderm of E7 embryos of diabetic mice (SD). 
C. In early somite-stage embryos of non-diabetic mice on E8, Raldh2 was 
expressed in the cephalic neural fold of the prospective forebrain (red 
arrowhead) and also in the somitic mesoderm (blue arrowhead). 
D. There was prominent reduction of Raldh2 expression in the cephalic neural 
fold of the prospective forebrain and the somitic mesoderm in E8 embryos 
of non-diabetic mice. 
E. In mid-gestation stage embryos of non-diabetic mice on E9, Raldh2 began to 
express in the region between the optic eminence and the first branchial arch 
(green arrowhead). Raldhl was also strongly expressed in the somitic 
mesoderm (blue arrowhead), along the dorso-lateral edges of the coelomic 
cavity (orange arrowhead) and in the hindgut diverticulum towards the base 
of the allantois (yellow arrowhead). 
F. Expressions of Raldhl in E9 embryos of diabetic mice were prominently 
reduced in all domains. 
Label: Blue arrowhead, somitic mesoderm 
Broken circle, embryonic mesoderm 
Green arrowhead, region between optic eminence and first branchial 
arch 
Orange arrowhead, dorso-lateral edges of coelomic cavity 
Red arrowhead, cephalic neural fold of prospective forebrain 
Yellow arrowhead, hindgut diverticulum towards the base of allantois 
Scale bar: A and B, 0.2 mm; C to F, 0.5 mm 
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Figure 3.3 In situ hybridization patterns of RaldhS in E9 embryos of 
diabetic and non-diabetic mice. 
A. RaldhS was strongly expressed in the optic and frontonasal regions (broken 
circle) of embryos of non-diabetic mice (ND). 
B. The expression of RaldhS in the optic and frontonasal regions in embryos of 
diabetic mice (SD) was prominently reduced. 
Label: Broken circle, optic and frontonasal regions 



















Graph 3.1 Relative expression levels of Raldhl in embryos of 
diabetic (SD) and non-diabetic (ND) mice at different 
developmental stages. 
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Graph 3.2 Relative expression levels of Raldhl in embryos of 
diabetic (SD) and non-diabetic (ND) mice at different 
developmental stages. 
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Graph 3.3 Relative expression levels of RaldhS in embryos of 
diabetic (SD) and non-diabetic (ND) mice at different 
developmental stages. 
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Graph 3.4 In vitro RA synthesizing activity of Raldh2 in embryos of 
diabetic (SD) and non-diabetic (ND) mice at different 
developmental stages. 
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Effect of Hyperglycemia on 
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4.1 INTRODUCTION 
It has been shown that rat embryos cultured in high glucose medium 
exhibited a variety of malformations. For instance, exencephaly, spina bifida, 
torsion defects and growth retardation were commonly observed (Cockroft and 
Coppola, 1977; Sadler, 1980; Ellington, 1997). Elevated concentrations of glucose 
will increase the influx of glucose into the embryo through glucose transporters. 
Without down-regulation of the glucose transporters, the workload of 
mitochondria increases and enhances the production of ROS. Failure of 
maintaining an optimum level of ROS results in lipid peroxidation. In the 
presence of high levels of ROS, the ROS scavenging system cannot fully develop 
in the embryo. Furthermore, hyperglycemia can disrupt the antioxidant defense 
system by inhibiting the enzyme for synthesis of the key antioxidant glutathione 
(GSH). Increased production of ROS and GSH deficiency will result in damages 
to the differentiating and proliferating embryonic tissues (Eriksson and Borg, 
1993; Sakamaki et al, 1999). It has been demonstrated that administration of 
GSH to diabetic pregnant rats could restore GSH concentrations in the embryo 
and reduced ROS formation, which successfully rescued neural and non-neural 
lesions and prevented growth retardation in embryos (Sakamaki et al, 1999). 
Moreover, DNA mutation was commonly observed in both hyperglycemic- and 
diabetic-induced embryonic dysmorphogenesis (Lee et al, 1999). 
Apoptosis is indispensable for normal embryonic development. During 
headfold stage, apoptotic cells are commonly observed in primordial tissues, such 
as the cardiogenic region, but disappeared at later stage after formation of the 
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primitive heart tube (Poelmann et al., 1998). Similarly, apoptotic cells are also 
commonly observed in the foregut diverticulum at headfold stage, but disappear 1 
to 2 days later, while new apoptotic cells are detected in the mid-gut and hindgut 
(Sun et al., 2002). On the other hand, apoptosis can be induced by elevated 
oxidative stress, which plays a critical role in the etiology of several 
complications associated with diabetic pregnancy. It has been reported that there 
is significant increase in apoptotic cells in the neuroepithelim at the region of the 
developing brain in the embryos of diabetic mice (Phelan et al, 1997). 
Concomitantly, neural tube defects are common congenital malformations in 
diabetic pregnancy. One suggested mechanism is that hyperglycemia inhibits 
PaxS expression in the embryo and further activates the j!753-dependent apoptotic 
pathway, thereby leading to a variety of birth defects (Pani et al., 2002; Morgan et 
al, 2008a). 
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4.2 EXPERIMENTAL DESIGN 
In Chapter 3, results show that maternal diabetes significantly 
down-regulates the mRNA expression of Raldhl, Raldh2 and RaldhS, and also 
reduces the in vitro RA synthesizing activity of Raldh2 enzymes in the embryos. 
However, the underlying mechanism is unclear. In the maternal diabetic milieu, 
many factors are being altered. For example, there are elevated levels of glucose, 
somatomedin inhibitors and ketone bodies. Previous studies have shown that these 
factors can exert adverse effects on embryo development (Horton and Sadler, 
1983; Sadler et al., 1986; Zusman and Omoy, 1987). Among them, the effect of 
hyperglycemia on embryogenesis is most well-studied. It has been shown in 
humans that tight glycemic control can reduce the risk of congenital 
malformations in diabetic pregnancy (Kitzmiller et al., 1991). Thus, the aim of 
this chapter was to test whether elevated glucose was the critical factor in the 
maternal diabetic milieu that caused a reduction in RA synthesis in the embryo. 
Both in vivo and in vitro approaches were employed. 
First, an in vivo experiment was conducted to determine whether 
reduction of blood glucose levels in the maternal diabetic milieu could normalize 
RA synthesis in the embryo. To achieve this, pregnant diabetic mice were treated 
with the drug phlorizin, which selectively reduced blood glucose level by 
inducing renal glucosuria via inhibition of glucose reabsorption in the proximal 
tubule of the kidney (Rossetti et al., 1987; Dimitrakoudis et al, 1992). After 
4 • 
injection of phlorizin or equivalent volume of the suspension vehicle (40% y -
propylene glycol in water) as the control to diabetic and non-diabetic pregnant 
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mice at regular intervals for 12 hours, embryos were collected on E9. Similar to 
Chapter 3，embryos were subjected to analysis of RA synthesis in terms of: (i) 
expression of Raldh mRNA detected by whole mount in situ hybridization and 
quantitative RT-PCR; (ii) in vitro RA synthesizing activity of Raldh enzymes. 
Next, to determine whether glucose could cause dose-dependent 
changes in RA synthesis in the embryo, an in vitro approach was employed. Rat 
embryos were cultured in rat serum supplemented with varying concentrations of 
D-glucose dissolved in DMEM or equivalent volume of the solvent as the control. 
The concentrations of D-glucose added was 2，3 and 4 mg/ml, which resulted in a 
culture condition with glucose concentrations approximately equivalent to 16.7, 
22.2 and 27.8 mmol/1 respectively. These glucose concentrations were within the 
range of blood glucose concentrations normally exhibited by our diabetic mice. In 
this experiment, rat embryos instead of mouse embryos were employed for whole 
embryo culture because preliminary studies found that rat embryos developing in 
culture showed a more consistent response to glucose treatment than mouse 
embryos. In this experiment, rat embryos were cultured in vitro from early 
headfold stage to 25-27 somite-stage, during which the embryo underwent 
organogenesis, including neural tube, heart, somites and limb buds formation. The 
development of rat embryos cultured in vitro closely mimics embryos growing in 
litem. Hence, whole embryo culture system is commonly employed for testing the 
effects of teratogens, such as glucose, on embryo development, since the effect of 
other factors that may also be altered in vivo can be excluded using the embryo 
culture system. Moreover, different dosages of D-glucose can be accurately 
applied to the culture medium. At the end of 48 hour of culture, the gene 
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expression level and the in vitro RA synthesizing activity of Raldh2 were 
determined as previously described. Only Raldh2 was assessed because as shown 
in Chapter 3, Raldhl is the dominant isoform in the mid-gestation mouse embryo. 
Thus, any dose-dependent changes in response to glucose could be most easily 
distinguishable. 
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4.3 MATERIALS AND METHODS 
4.3.1 Phlorizin treatment 
The maternal blood glucose level of diabetic pregnant mice was 
reduced by intraperitoneal injection of phlorizin that induced renal glucosuria. 
Phlorizin (Sigma) was prepared by dissolving in 40% propylene glycol (Sigma) in 
water to make a stock at the concentration of 0.04 g/ml. Starting from hour 14 on 
E8.0 (i.e. 12:00 am), diabetic and non-diabetic pregnant mice received 
intraperitoneal injection of 0.4 g/kg phlorizin or equivalent volume of suspension 
vehicle as control at 4-hour intervals for a total of 3 doses. Maternal blood glucose 
level was measured prior to each injection and also prior to dissection. At 12:00 
pm on E9, conceptuses were removed from the uterus and embryos were dissected 
out in DEPC-treated ice-cold PBS and freed from all extraembryonic tissues. 
Embryos between 19-20 somite-stage were collected for real-time quantitative 
RT-PCR and in vitro RA synthesizing activity studies as described in sections 
4.3.5 and 4.3.6 respectively. 
4.3.2 Whole rat embryo culture 
Pregnant SD rat was sacrificed on E9.5 (12:00 pm). Embryos were 
dissected out in PBl medium added with 10% fetal bovine serum. There were 
variations in the developmental stage of embryos within and between litters. To 
minimize differences in response to glucose due to variations in developmental 
stage (Cockroft, 1984), only embryos at early headfold stage, identified by 
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morphological landmarks as described in Downs and Davies (1993), were 
selected for culture. All decidual tissues were removed, while the ectoplacental 
cone and yolk sac remained intact. Three embryos were placed in a culture bottle 
containing 3 ml of rat serum (refer to section 4.3.3 for preparation of rat serum) 
supplemented with varying concentrations of D-glucose [2，3 and 4 mg/ml; stock: 
0.5 g/ml D-glucose dissolved in DMEM {Gibco)] or the solvent (DMEM) as 
control. Culture bottles were fitted onto a culture unit rotating at 60 rpm inside an 
incubator (BTC engineering) at 38°C. The culture period was 48 hours, during 
which embryos were continuously gassed with a gas mixture containing 5% O2, 
5% CO2 and 90% N2 in the first 24 hours, 20% O2, 5% CO2 and 75% Nzin the 
next 8 hours, and 40% O2, 5% CO2 and 55% N2 in the last 16 hours. After 48 
hours of culture, embryos were dissected in DEPC-treated ice-cold PBS and 
dissected from all extraembryonic tissues. They were collected for whole mount 
in situ hybridization, real-time quantitative RT-PCR and in vitro RA synthesizing 
activity studies as described in sections 4.3.4 and 4.3.5 and 4.3.6 respectively. 
4.3.3 Preparation of rat serum 
Rat serum was prepared according to the method as described in 
Cockroft (1990). In brief, adult male SD rat was anaesthetized by ether. The 
abdominal wall was cut open and blood was collected using a 21 gauge syringe 
needle inserted into the dorsal aorta. Blood sample was immediately centrifuged 
for 5 minutes at 4,000 rpm and the serum was transferred to a new tube. The 
serum was heat-inactivated at 56°C in. a water bath for 40 minutes, during which 
the serum was gassed with a gentle stream of nitrogen gas to remove any residual 
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ether. The serum was stored at -80°C until use. 
4.3.4 In situ hybridization 
Rat embryos dissected free from all extraembryonic membranes were 
fixed in 4% paraformaldehyde overnight and then processed for whole mount in 
situ hybridization analysis of Raldh2 gene expression pattern according to the 
protocol as described in section 2.4 and using Raldhl mouse cDNA plasmid with 
particulars as detailed in section 3.3.1.2. A mouse instead of rat Raldh2 cDNA 
plasmid was used because only the mouse Raldh2 cDNA plasmid was available in 
our laboratory. However, mouse and rat Raldh2 share 95% homology and thus the 
mouse Raldhl cDNA can also specifically detect rat Raldh2. Between 9 to 12 
embryos were examined for each group. 
4.3.5 Real-time quantitative RT-PCR 
After embryos were dissected free from all extraembryonic tissues, 
mouse embryos from the same litter were pooled together as one sample, whereas 
the 3 rat embryos cultured in the same bottle were pooled together as one sample. 
Samples were stored in RNAlater solution at -20°C until use. 
Mouse embryo samples were subjected to quantification of Raldhl, 
Raldhl and RaldhS mRNA expression levels by real-time quantitative RT-PCR 
using primers as described in section 3.3.1.3 and protocols as described in section 
2.5. The housekeeping gene p-actin was used as the internal control for 
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normalization of PGR products of Raldhl, whereas a less abundant housekeeping 
gene Transferrin Receptor (Tfrc) was used as the internal control for 
normalization of PGR products of Raldhl and RaldhS because of their relatively 
low expression levels. The sequences of primers used for amplification of mouse 
P-actin were described in section 3.3.1.3 and those for amplification of Tfrc were 
detailed below. The PGR product amplified was a 189 bp sequence corresponding 
to nucleotide sequences 2223-2242 and 2411-2392 of mouse Tfrc. Between 7 to 8 
litters of embryos were analyzed for each group. 
Rat embryo samples were subjected to quantification of Raldhl 
mRNA expression levels by real-time quantitative RT-PCR using protocols as 
described in section 2.5. The housekeeping gene p-actin was used as the internal 
control for normalization of PGR products. The sequences of primers used for 
amplification of Raldh2 and p-actin were detailed below. The PGR products 
amplified were: a 160 bp sequence corresponding to nucleotide sequences 
1666-1685 and 1825-1806 of rat Raldhl^ and a 266 bp sequence corresponding to 
nucleotide sequences 24-43 and 289-270 of rat p-actin. 
Sequences of primers: 
Rat Raldhl forward primer: 5'-TTG CCT CAC AAC AAG TGA GC-3' 
reverse primer: 5'-ATT TGG CAG CTC AGG AGA GA-3' 
Rat P-actin forward primer: 5'-CGA GTA CAA CCT TCT TGC AG-3’ 
reverse primer: 5'-GGT ACT TCA GGG TCA GGA TG -3， 
Mouse Tfrc forward primer: 5，-CAC TTC CTG TCG CCC TAT GT-3’ 
reverse primer: 5’-TGC GAC TCC CTG AAT AGT CC-3' 
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4.3.6 In vitro RA synthesizing reaction 
After embryos were dissected free from all extraembryonic tissues, 
mouse embryos from the same litter were pooled together as one sample, whereas 
the 3 rat embryos culturing in the same bottle were pool together as one sample. 
Samples were snap frozen in liquid nitrogen and stored at -80�C until used. 
The sample was subjected to separation of the three isoforms of Raldh 
enzymes by lEF as described in section 2.7. Mouse embryo sample of the 
non-diabetic control group or rat embryo sample of the control group without lEF 
processing and added with the RA synthesizing enzyme inhibitor citral served as 
the negative control. The RA synthesizing activity was measured by an in vitro 
assay as described in section 2.8. The amount of RA being synthesized was 
quantified by using the RA-responsive cell line as described in section 2.6. The 
RA synthesizing activity was defined by the concentration of RA in nM 
synthesized by 1 |ig of whole embryo protein lysate applied to lEF. Between 7 to 
8 samples were analyzed for each group. 
4.3.7 Statistical analyses 
The maternal blood glucose level before and after treatment was 
analyzed by Paired Samples t-test. The mRNA expression level of Raldhl, Raldhl 
and RaldhS and the in vitro RA synthesizing activity of Raldh2 enzymes between 
embryos of diabetic and non-diabetic.mice injected with phlorizin or suspension 
vehicle were analyzed by one-way Analysis of Variance (ANOVA) followed by 
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Bonferroni test. 
The expression level of Raldhl gene and in vitro RA synthesizing 
activity of Raldh2 enzymes in embryos cultured in medium containing varying 
concentrations of D-glucose were tested against the control group by Independent 
Samples t-test. To further determine whether there was any dose-dependent 
relationship between the concentration of D-glucose supplemented in the culture 
medium and the mRNA expression level of Raldh2 or the in vitro RA synthesizing 
activity of Raldh2 enzymes, Pearson's Correlation was employed to test whether 
there was any linear correlation between these 2 variables. This test will generate 
a Pearson's correlation coefficient (r) with values ranging from +1 to -1. If the 
value is close to +1, that means there is a strong positive linear relationship 
between the 2 variables. In contrast, if the value is close to -1, it means that there 
is a strong negative linear relationship between the 2 variables. A value equals to 
zero means that there is no linear correlation between the 2 variables. The t-test is 
then used to establish if the correlation coefficient is significantly different from 
zero，with ap-value showing the significance level of linearity. 
All statistical analyses were performed using SPSS software (SPSS), 
with statistical significance level set at/? < 0.05. 
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4.4 RESULTS 
4.4.1 Comparison of the relative expression level of RaldhI，RaldhI and 
RaldhS between embryos of diabetic and non-diabetic mice injected 
with phlorizin or suspension vehicle as control 
The maternal blood glucose level of diabetic and non-diabetic mice 
before and after injection of phlorizin or suspension vehicle as control was 
summarized in Table 4.1. 
Table 4.1 Maternal blood glucose levels of diabetic (SD) and non-diabetic (ND) 
mice before and after treatment with phlorizin (PHZ) or suspension 
vehicle as control (CON). 
Treatment groups ND(CON) ND(PHZ) SD(CON) SD(PHZ) 
No. of litters 8 8 8 8 
Blood glucose levels ± 5 卯 3 , 3 28.73 28.41 
SEM(mmol/l) prior 送63 • 士 0.63 士 4.47 士 4.06 
to treatment 
Blood glucose levels 士 ^ ^^  6.05 28.30 10.56 
SEM (mmol/1) prior 
、 士 0.75 士 0.65 士 4.08 士 1.78 to embryo collection 
/ 7 - v a l u e i n c o m p a r i n g 
blood glucose levels ^ 0.084 0.545 0.755 <0.001* before and after 
treatment 
* Statistically significant (Paired Samples t-test) 
Results showed that injections of phlorizin or suspension vehicle did 
not have any effect on blood glucose levels of non-diabetic mice. However, 
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maternal blood glucose levels of diabetic mice were significantly reduced from 
28.41 to 10.56 mmol/1 after receiving 3 doses of phlorizin, whereas diabetic mice 
injected with suspension vehicle had no changes in blood glucose level. As 
mentioned in section 2.2, mice with blood glucose levels reaching 16.7 mmol/1 or 
higher are regarded as diabetic. These results showed that phlorizin could 
successfully induce a lowering of maternal blood glucose of diabetic mice to a 
sub-diabetic level in this experiment. 
Results of the relative expression level of the 3 isoforms of Raldh and 
statistical analyses were summarized in Table 4.2 and Table 4.3 respectively, and 
presented in Graph 4.1 for Raldhl, Graph 4.2 for Raldh2 and Graph 4.3 for 
RaldhS. 
Table 4.2 Relative expression levels of different isoforms of Raldh in embryos of 
diabetic (SD) and non-diabetic (ND) mice treated with phlorizin (PHZ) 
or suspension vehicle as control (CON). 
Treatment groups ND(CON) ND(PHZ) SD(CON) SD(PHZ) 
No. of litters 8 8 8 8 
Expression levels of 0.31 0.28 0.17 0.33 
RaldhHTfrc 士 SEM 士 0.03 士 0.03 ± 0.01 ± 0.03 
Expression levels of 1.25 1.32 0.96 1.17 
Raldhl!P-actin 土 SEM 土 0.01 士 0.03 士 0.01 士 0.01 
Expression levels of 1.95 2.04 1.08 1.9 
及 土 SEM 士 0.13 ±0.16 士 0.07 ±0.28 
- 7 1 -
Chapter 4: Hyperglycemia and RA Synthesis 
Table 4.3 The p-value of comparing the relative expression level of different 
isoforms of Raldh in embryos of diabetic (SD) and non-diabetic (ND) 
mice treated with phlorizin (PHZ) or suspension vehicle (CON) as 
control. 
ND(CON) ND(CON) ND(CON) ND(PHZ) ND(PHZ) SD(CON) Groups for vs. vs. vs. vs. vs. vs. comparison 
ND(PHZ) SD(CON) SD(PHZ) SD(CON) SD(PHZ) SD(PHZ) 
Raldhl 1.000 < 0.05* 1.000 <0.05* 1.000 <0.01* 
Raldh2 1 . 0 0 0 < 0 . 0 1 * 1.000 <0.001* 0 . 3 7 1 < 0 . 0 5 * 
RaldhS 1.000 <0.05* 1.000 <0.01* 1.000 . < 0.05* 
* Statistically significant (One-way ANOVA followed by Bonferroni test) 
Consistent with the finding that phlorizin did not cause any changes in 
maternal blood glucose levels of non-diabetic mice, there were no differences in 
the expression levels of Raldhl (Graph 4.1), Raldhl (Graph 4.2) and RaldhS 
(Graph 4.3) between embryos of non-diabetic mice treated with phlorizin and 
those control embryos treated with suspension vehicle. In agreement with the 
results in Chapter 3 that expressions of all 3 isoforms of Raldh were significantly 
down-regulated in embryos of diabetic mice (Graphs 3.1，3.2 and 3.3), in this 
experiment, embryos of diabetic mice treated with suspension vehicle had • 
significantly lower levels of expression of Raldhl, Raldh2 and RaldhS in “ 
comparison to embryos of non-diabetic mice. However, concomitant with a 
lowering of maternal blood glucose to sub-diabetic levels, the expression of all 3 
isoforms of Raldh in embryos of diabetic group treated with phlorizin were 
significantly up-regulated to a level similar to that of embryos of non-diabetic 
mice. 
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After confirming that a lowering of maternal blood glucose level of 
diabetic mice could normalize the expression level of Raldh genes, experiments 
were conducted to determine if there was a corresponding normalization of the in 
vitro RA synthesizing activity of Raldh enzymes, with results presented in the 
following section. 
4.4.2 Comparison of the in vitro RA synthesizing activity of different 
isoforms of Raldh enzymes between embryos of diabetic and 
non-diabetic mice injected with phlorizin or suspension vehicle as 
control 
The maternal blood glucose level of diabetic and non-diabetic mice 
before and after injection of phlorizin or suspension vehicle as control was 
summarized in Table 4.4. 
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Table 4.4 Maternal blood glucose levels of diabetic (SD) and non-diabetic (ND) 
mice before and after treatment with phlorizin (PHZ) or suspension 
vehicle (CON) as control. 
Treatment groups ND(CON) ND(PHZ) SD(CON) SD(PHZ) 
No. of litters 8 8 8 8 
Blood glucose levels 士 ^ 6.64 6.39 27.24 25.03 SEM (mmol/1) prior … � 一^ … 
^ 士 0.18 士 0.29 士 0.90 士 1.24 to treatment 
Blood glucose levels 土 b 6.98 7.18 26.95 11.55 SEM (mmoI/1) prior … … … … - 士 0.25 ±0.52 ±0.92 士 0.38 to embryo collection 
/7-value in comparing 
blood glucose levels ^ 0.229 0.114 0.791 <0.001* before and after 
treatment 
* Statistically significant (Paired Samples t-test) 
Consistent with the finding in the previous experiment (section 4.4.1)， 
on the differential effect of phlorizin on diabetic and non-diabetic mice, results in 
Table 4.4 confirmed that for the batch of mice employed in this set of experiments, 
only the diabetic group treated with phlorizin showed a significant reduction of 
maternal blood glucose to a sub-diabetic level, whereas no significant changes of . 
maternal blood glucose levels were found in the non-diabetic group treated with . 
phlorizin or both groups treated with suspension vehicle. 
Results of the in vitro RA synthesizing activity of the 3 isoforms of 
Raldh enzymes and statistical analyses were summarized in Table 4.5 and Table 
4.6 respectively, and presented in Graph 4.4 for Raldh2. 
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Table 4.5 In vitro RA synthesizing activity of different isoforms of Raldh in 
embryos of diabetic (SD) and non-diabetic (ND) mice treated with 
phlorizin (PHZ) or suspension vehicle as control (CON). 
ND(CON) Treatment groups ND(CON) ND(PHZ) SD(CON) SD (PHZ) + Citral 
No. of litters 8 8 8 8 4 
Amount of RA 
synthesized by Raldhl UD UD UD UD UD 
土 SEM (nM/ug protein) 
Amount of RA 0.128 0.110 0.072 0.124 • synthesized by Raldh2 UD I ^ 】 土 0.010 ±0.013 士 0.009 士 0.010 土 SEM (nM/ug protein) 
Amount of RA 
synthesized by Raldh3 UD UD UD UD UD 
土 SEM (nM/ug protein) 
UD: undetectable 
Table 4.6 The value of comparing the in vitro RA synthesizing activity of 
Raldh2 between embryos of diabetic (SD) and non-diabetic (ND) mice 
treated with phlorizin (PHZ) or suspension vehicle as control (CON). 
ND(CON) ND(CON) ND(CON) ND(PHZ) ND(PHZ) SD(CON) Groups for vs. vs. vs. vs. vs. vs. comparison ND(PHZ) SD(CON) SD(PHZ) SD(CON) SD(PHZ) SD(PHZ) 
Raldh2 1.000 <0.01* 1.000 < 0.05* 1.000 <0.01* ‘ 
* Statistically significant (One-way ANOVA followed by Bonferroni test) 
Similar to the findings in Chapter 3 (section 3.4.3)； the RA 
synthesizing activity of Raldhl and RaldhS in all treatment groups, measured in 
terms of the amount of RA being synthesized in vitro from the precursor dXX-trans 
- 7 5 -
Chapter 4: Hyperglycemia and RA Synthesis 
retinal, were below the detection limit of the RA-responsive cell line. 
In parallel with the findings that no significant changes in the maternal 
blood glucose level (Table 4.4) and the mRNA expression level of Raldh2 (Graph 
4.2) were detected in the diabetic group treated with suspension vehicle, or the 
non-diabetic group treated with phlorizin or suspension vehicle, there were no 
significant changes in the in vitro RA synthesizing activity of Raldh2 in these 
treatment groups. However, concomitant with a lowering of maternal blood 
glucose to sub-diabetic levels and normalization of the mRNA expression level of 
Raldh2 (Graph 4.2), the in vitro RA synthesizing activity of Raldh2 enzymes in 
embryos of diabetic mice receiving phlorizin treatment was significantly 
increased to a level similar to that of embryos of non-diabetic mice. In the 
negative control in which citral, an inhibitor of RA synthesizing enzymes, was 
added into the medium containing the same amount of protein lysate, no RA was 
detected, confirming that RA was synthesized by RA synthesizing enzymes 
present in the protein lysate of the sample. 
Taken together, results of the in vivo experiments in normalizing 
Raldhl mRNA expression levels and the in vitro RA synthesizing activity of . 
Raldh2 enzyme by lowering the maternal blood glucose level of diabetic mice • 
support that elevated glucose is a critical factor in the maternal diabetic milieu 
that affects RA synthesis in the embryo. However, to further decipher whether 
glucose could cause dose-dependent changes in RA synthesis, an in vitro 
experiment was conducted with results reported in the following section. 
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4.4.3 In situ expression pattern of Raldh2 in rat embryos cultured in 
medium containing varying concentrations of D-glucose 
The expression pattern of Raldhl in rat embryos cultured for 48 hours 
in medium supplemented with varying concentrations of D-glucose or the solvent 
DMEM as control was shown in Figure 4.1. 
At around mid-gestation, there is a two-day difference in the 
developmental rate between mouse and rat embryos. Similar to the expression 
pattern of E9 mouse embryos (Figure 3.2), the expression domains of Raldhl in 
cultured control rat embryos, at a stage equivalent to El 1.5 rat embryos developed 
in utero, was mainly found in the region between the optic eminence and the first 
branchial arch, in the somites and pre-somitic mesoderm, in a lateral domain 
corresponding to cells along the dorso-lateral edges of the coelomic cavity, and in 
the hindgut diverticulum towards the base of the allantois (Figure 4.1). However, 
embryos cultured in hyperglycemic conditions exhibited malformations, such as 
neural tube defects, torsion defects and caudal regression. The severity of 
malformation increased as the concentration of glucose increased. There was a 
reduction in the expression level of Raldhl in the glucose-treated groups in • 
comparison to the control (Figures 4.1C, 4.IE and 4.1G). A dose-dependent • 
change could be illustrated in the expression pattern of Raldh2 in the region 
between the optic eminence and the first branchial arch (Figure 4.IB), which 
gradually diminished in response to an increase in the concentration of D-glucose 
in the culture medium (Figures 4.1D, 4.1F and 4.1H). 
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4.4.4 Relative expression levels of Raldhl in rat embryos cultured in 
medium supplemented with varying concentrations of D-glucose 
Results of the relative expression level of Raldh2 in rat embryos 
cultured for 48 hours in medium supplemented with varying concentrations of 
D-glucose and statistical analyses were summarized in Table 4.7 and presented in 
Graph 4.5. 
Table 4.7 Relative expression levels of Raldh2 in rat embryos cultured in 
medium supplemented with varying concentrations of D-glucose or the 
solvent DMEM as control. 
Concentrations of D-glucose Control 2 mg/ml 3 mg/ml 4 mg/ml 
Sample size 7 7 7 7 
Expression levels of 1.49 0.95 0.78 0.49 
Raldh2/fi-actin 士 0.080 士 0.101 士 0.120 士0.039 
/7-value vs. control by N/A <0.01* <0.01* <0.01* Independent Samples t-test 
% difference from control N/A -33% -39% -68% 
r-value of Pearson's . ^^ • -0.866 correlation coefficient 
/7-value of Pearson's <0.001* correlation coefficient 
N/A: not applicable; * Statistically significant 
Results showed that the expression level of Raldh2 was significantly 
down-regulated by 33%, 39% and 68% in 2, 3 and 4 mg/ml D-glucose groups 
respectively when compared with the control group, indicating that the expression 
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level of RaldhI in the rat embryo could indeed be altered by the D-glucose 
exogenously added into the culture medium. Results of statistical analysis by 
Pearson's correlation further confirmed that there was a significant 
dose-dependent change in the Raldh2 expression level of rat embryos in response 
to D-glucose added into the culture medium. Moreover, the Pearson's coefficient 
was -0.866，meaning that the RaldhI expression level and the concentration of 
D-glucose was negatively correlated to each other, i.e. the higher the glucose 
concentration in the culture medium, the lower the Raldh2 expression level in the 
embryo. 
To determine if a dose-dependent down-regulation of the mRNA 
expression level of Raldh2 in response to elevated glucose was accompanied by a 
dose-dependent change in RA synthesis, the in vitro RA synthesizing activity of 
Raldh2 enzyme was measured, with results reported in the following section. 
4.4.5 In vitro RA synthesizing activity of Raldh2 in rat embryos cultured 
in medium supplemented with varying concentrations of D-glucose 
Results of the in vitro RA synthesizing activity of Raldh2 in rat 
embryos cultured for 48 hours in medium supplemented with varying 
concentrations of D-glucose and statistical analysis were summarized in Table 4.8 
and presented in Graph 4.6. 
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Table 4.8 In vitro RA synthesizing activity of Raldh2 in rat embryos cultured in 
medium supplemented with varying concentrations of D-glucose or the 
solvent DMEM as control. 
Concentrations of Control Control 2 mg/ml 3 mg/ml 4 mg/ml D-glucose ^ ^ ^ (Citral) ^^^^^^^B^saBssssaasB^^^^^^^^m aa^^^^^sasBa^^^^s^^^^B^EK B^aaBsaaasBBBEBasa •saBEBaBanaaanaaBBB^^^B^^^B 
Sample size 6 6 6 6 3 
Amount of RA , o.033 0.028 0.022 
synthesized by ^ ^ 
Raldh2 土 SEM 
±0.0039 ±0.0021 ±0.0015 ± 0.0020 
(nM/ng protein) 
p-value of Student ^ N/A 0.13 < 0.05* <0.01* N/A ^-test vs. control % difference from N/A -19% -31% -46% -100% 
control 
Pearson's coefficient -0.758 N/A 
p-value of Pearson's 
^ <0.001* N/A correlation N/A: not applicable; UD: undetectable; * Statistically significant 
In this set of experiment, the in vitro RA synthesizing activity of 
Raldh2 in rat embryos cultured in 2，3 and 4 mg/ml D-glucose was reduced by 
19%, 31% and 46% respectively. Although only the reduction in 3 and 4 mg/ml ‘ 
D-glucose groups, but not the 2 mg/ml D-glucose group, reached a statistically 
significant difference from the control group, statistical analysis by Pearson's 
correlation confirmed that there was a significant dose-dependent change in the in 
vitro RA synthesizing activity of rat embryos in response to the concentration of 
D-glucose in the culture medium. Moreover, the Pearson's coefficient was -0.758， 
meaning that the in vitro RA synthesizing activity and the concentration of 
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D-glucose was negatively correlated to each other, i.e. the higher the D-glucose 
concentration in the culture medium, the lower the in vitro RA synthesizing 
activity of the embryo. In the negative control in which citral, an inhibitor of RA 
synthesizing enzymes, was added into the medium containing the same amount of 
protein lysate, no RA was detected, confirming that RA was synthesized by RA 
synthesizing enzymes present in the protein lysate of the sample. 
Taken together, results showed that concomitant with a dose-dependent 
down-regulation of Raldh2 expression, hyperglycemia could ‘ cause a 
dose-dependent reduction in RA synthesis. 
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4.5 DISCUSSION 
The aim of this chapter was to test whether elevated glucose was the 
critical factor in the maternal diabetic milieu that caused a reduction in RA 
synthesis in the embryo. Indeed, the in vivo experiment on injection of phlorizin 
to diabetic mice has demonstrated that transient reduction of maternal blood 
glucose level could normalize RA synthesis. Moreover, results of the in vitro 
experiment further demonstrated that there was a dose-dependent inverse 
relationship between the concentration of D-glucose and RA synthesis in the 
embryo. 
Although the molecular pathway of the teratogenic effect of 
hyperglycemia on embryos is still far from clearly understood, some possible 
factors may be involved in the pathway leading to congenital malformations. 
Many findings show that oxidative stress is increased in rodent embryos in 
diabetic pregnancy (Damasceno et al., 2002). Oxidative stress results when the 
rate of oxidant production exceeds the rate of oxidant degradation. During 
diabetic pregnancy, excess influx of glucose into the mitochondria will increase 
production of ROS (Nishikawa et al., 2000). It is well known that oxidative stress -
caused by elevated glucose increases lipid peroxidation (Wentzel et al., 1999). It • 
has been shown that lipid peroxidation can inhibit RA synthesis in vitro (Chen and 
Juchau, 1998). Thus it is possible that the increase in lipid peroxidation under 
hyperglycemic conditions may suppress Raldh gene expression and RA synthesis 
in the embryo. Since RA is important for development of many organ systems, 
such as the brain (Niederreither et al, 2000); heart (Niederreither et al., 2001)， 
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forelimb (Niederreither et al, 2002c) and the kidney (Rosselot et al, 2010), 
down-regulation of Raldh genes and RA synthesis may lead to malformations of 
these organ systems. This may shed light on why the types of malformations that 
show increased incidences in diabetic pregnancy are highly similar to those 
observed in cases of disruption in RA homeostasis (Kucera, 1971). 
Apart from altering cell signaling pathway, oxidative stress can also 
affect gene expression leading to congenital malformations. It has been reported 
that maternal diabetes- or hyperglycemia-induced oxidative stress alters the 
expression level of Pax3 in the mouse embryo (Phelan et al., 1997; Fine et al, 
1999). Pax3 is a member of the paired box family of transcription factors that 
controls neural and cardiac development (Epstein et al, 1991; Conway et al, 
1997). Pax3 expression was inhibited by elevated levels of maternal oxidative 
stress and certain malformations, such as neural tube defects and cardiac outflow 
tract defects, were observed (Chang et al., 2003; Morgan et al, 2008b). It has 
been found that there is a RARE located in the promoter region of Pax3 (Kennedy 
et al., 2009), thus the transcription of this gene can be directly triggered by the 
binding of RA-RA receptors complex. It is possible that the down-regulation of 
Pax3 is caused by reduction of RA levels in the embryo as a result of increase in . 
oxidative stress under hyperglycemia. It has been reported that injection of • 
phlorizin to diabetic mice could normalize Pax3 and reduced the incidence of 
neural tube defects in the embryos (Fine et al., 1999). Based on the finding in this 
chapter, it is tempting to suggest that a lowering of the maternal blood glucose 
level normalizes RA synthesis in the embryos of diabetic mice, which restores 
Pax3 expression and thereby rescuing the embryos from developing neural tube 
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defects. 
Taken together, results of this chapter clearly demonstrate an inverse 
dose-dependent relationship between the concentration of glucose and RA 
synthesis. However, whether hyperglycemia-induced reduction of RA synthesis 
indeed increases the risk of congenital malformations is still unclear. Hence, in the 
next chapter, an in vitro experiment was conducted to determine whether 
supplementation with exogenous RA could rescue embryos from 
hyperglycemia-induced malformations. 
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Figure 4.1 Expression patterns of Raldhl in rat embryos cultured for 48 
hours in medium supplemented with varying concentrations of 
D-glucose or the solvent DMEM as control. 
A. Raldh2 was strongly expressed in the region between the optic eminence and 
the first branchial arch (green arrowhead) in embryos of the control group. 
Raldh2 was also expressed in the somitic mesoderm (blue arrowhead), along 
the dorso-lateral edges of the coelomic cavity (orange arrowhead) and in the 
hindgut diverticulum towards the base of the allantois (yellow arrowhead). 
B. Higher magnification of the cranial region of the embryo in A to show the 
broad expression domain of Raldhl in the region between the optic 
eminence and the first branchial arch. 
C. For embryos cultured in medium supplemented with 2 mg/ml D-glucose, 
there was a general reduction in the expression level of Raldhl in all 
domains in comparison to the control embryo. 
D. Higher magnification of the cranial region of the embryo in C showed that 
the expression of Raldhl in the region between the optic eminence and the 
first branchial arch was prominently reduced in comparison to the control 
embryo. 
E. Embryos cultured in medium supplemented with 3 mg/ml D-glucose showed 
retardation and were malformed. The expression of Raldhl in all expression 
domains was further reduced. 
F. Higher magnification of the cranial region of the embryo in E showed that 
the forebrain was poorly developed. Raldh2 was weekly expressed in the 
region between the presumptive optic eminence and the first branchial arch. 
G Embryos cultured in medium supplemented with 4 mg/ml D-glucose showed 
increased severity of retardation and malformations in comparison to 
embryos of the 3 mg/ml D-glucose group. Raldh2 expression was further 
reduced in all expression domains. 
H. Higher magnification of the cranial region of the embryo in G showed that 
forebrain development was severely affected. The expression of Raldh2 in 
the region between the presumptive optic eminence and the first branchial 
arch had almost diminished. 
Label: Blue arrowhead, somitic mesoderm 
Green arrowhead, region between optic eminence and first branchial 
arch 
Orange arrowhead, dorso-lateral edges of coelomic cavity 
Yellow arrowhead, hindgut diverticulum towards the base of allantois 
Scale bar: A, C, E and Q 0.5 mm; B, D, F and H, 0.2 mm 
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Graph 4.1 Relative expression levels of RaldhI in embryos of 
diabetic (SD) and non-diabetic (ND) mice injected with 
phlorizin (PHZ) or suspension vehicle as control (CON). 
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Graph 4.2 Relative expression levels of Raldh2 in embryos of 
diabetic (SD) and non-diabetic (ND) mice injected with 
phlorizin (PHZ) or suspension vehicle as control (CON). 
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Graph 4.3 Relative expression levels of RaldhS in embryos of 
diabetic (SD) and non-diabetic (ND) mice injected with 
phlorizin (PHZ) or suspension vehicle as control (CON). 
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Graph 4.4 In vitro RA synthesizing activity of Raldh2 in embryos of 
diabetic (SD) and non-diabetic (ND) mice injected with 
phlorizin (PHZ) or suspension vehicle as control (CON). 
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Graph 4.5 Relative expression levels of Raldhl in rat embryos 
cultured for 48 hours in medium supplemented with 
varying concentrations of D-glucose or the solvent 
DMEM as control. 
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Graph 4.6 The RA synthesizing activity of Raldh2 in rat embryos 
cultured for 48 hours in medium supplemented with 
varying concentrations of D-glucose or the solvent 
DMEM as control. 
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5.1 INTRODUCTION 
In Chapter 3, it has been confirmed that RA synthesis was reduced in 
embryos of diabetic mice. Moreover, as demonstrated in Chapter 4, lowering 
maternal blood glucose to a non-diabetic level normalized RA synthesis in 
embryos of diabetic mice, whereas rat embryos cultured in vitro in hyperglycemic 
conditions showed a dose-dependent reduction of RA synthesis. These results 
support that elevated glucose down-regulates RA synthesis in the embryo. 
A number of putative molecular mechanisms of how RA regulates 
embryogenesis have been proposed by different research groups. RA regulates 
trunk development by repressing the expression of Fgf8 so as to control 
differentiation during axis extension, somite segmentation (Diez del Corral et al, 
2003) and left-right symmetry (Sirbu and Duester, 2006). Similar to trunk 
development, early development of the heart requires the presence of RA 
(Ryckebusch et al., 2008). RA represses the expression of Fgf8 in the posterior 
region of the heart (Sirbu et al., 2008). 
RA is important for limb bud development. Several studies have •. 
revealed that RA synthesis in the tissues near the limb bud is controlled by Raldh2 • 
(Niederreither et al., 2002c; Mic et al, 2004). During limb bud induction, the 
expression of Shh is induced by RA. Rescue experiments have shown that 
supplementation of RA to Raldh2{-/-) mouse embryos could restore the expression 
of some genes, such as Tbx5, Meis2 and dHand, that are responsible for limb bud 
development (Mic et al, 2004). In addition, RA synthesis is also important for the • 
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development of the dorsal pancreas in zebrafish (Stafford and Prince, 2002), 
Xenopus (Chen et al., 2004), avian (Stafford et al., 2004) and mouse embryos 
(Martin et al., 2005) during organogenesis, showing that RA function is highly 
conserved. Several RA-related genes, such as Pdxl that regulates early pancreatic 
development (Offield et al., 1996) and Isl-1 that is responsible for the formation of 
the dorsal pancreas (Ahlgren et al., 1997), are found to be down-regulated in 
Raldh2(-/-) mouse embryos (Martin et al., 2005). 
Targeted deletions of both Raldhl and RaldhS result in severe ocular 
malformations of the eyelid, lens, cornea and retina in the mouse embryos (Matt 
et al., 2005; Molotkov et al., 2006). The expression level of several genes 
regulating ocular development, including Dkk2 and Pitx2, is reduced in Raldhl^-/-) 
and Raldh3{-/-) double mutants (Kumar et al., 2010). Both genes are expressed at 
a region called the periocular mesenchyme, which is derived from neural crest 
cells (Matt et al, 2005). 
Taken together, the malformations exhibited by Raldh mutant mouse 
embryos are commonly observed in embryos of diabetic pregnancy. It has been 
demonstrated that maternal supplementation with RA could rescue some of the 
malformations in Raldh mutant mouse embryos. Thus, it is possible that • 
supplementation of RA in vitro could ameliorate the teratogenic effect of 
hyperglycemia on the embryo. 
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5.2 EXPERIMENTAL DESIGN 
Results of Chapter 3 and Chapter 4 have established that RA synthesis 
in the embryo was reduced under diabetic or hyperglycemic conditions. However, 
whether reduction of RA synthesis indeed plays a role in increasing the risk of 
various congenital malformations that are commonly seen in diabetic pregnancy 
remains unclear. Thus, the objective of this chapter was to test whether in vitro 
supplementation of RA could ameliorate congenital malformations in embryos 
induced by hyperglycemia. 
To achieve this objective, headfold stage rat embryos were cultured in 
hyperglycemic conditions for 48 hours. As shown in Chapter 4, supplementation 
with 3 and 4 mg/ml D-glucose induced severe malformations, especially in the 
caudal and craniofacial regions of the embryos (Figure 4.1). Thus, these two 
dosages of D-glucose were employed to create the hyperglycemic conditions. In 
addition to D-glucose, the culture medium was supplemented with varying 
concentrations of RA (lO'^ ^M to lO'^ M) or the solvent as control. At the end of the 
culture period, the growth and development of the embryo was examined by a 
well-employed morphological grading system (Van Maele-Fabry et al, 1990) to •. 
determine whether exogenous RA supplementation could rescue embryos from • 
the adverse effect of hyperglycemia. 
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5.3 MATERIALS AND METHODS 
5.3.1 Preparation of RA 
RA stock, at a concentration of O.IM，was prepared by dissolving RA 
powder in DMSO in the dark to prevent photo-oxidation. The stock solution was 
stored at -80°C as small aliquots wrapped with aluminum foil. Working RA 
solutions were freshly-prepared by 10-fold serial dilution of RA stock with 
DMSO down to followed by 10-fold serial dilution with DMEM, so that 
the final concentrations of DMSO in the culture medium would not be higher than 
0.01% to prevent toxic effect of DMSO on embryo development. 
5.3.2 Supplementation of RA to rat embryos in culture 
As described in section 4.3.2，pregnant SD rats were sacrificed at E9.5. 
Embryos were dissected out and only those at early headfold stage were selected 
for culture. Three embryos were placed in a culture bottle containing 3 ml of rat 
serum added with 3 and 4 mg/ml D-glucose dissolved in DMEM or equivalent 
volume of solvent as control. In each of this group, the medium was further 
1 n 1 • 
supplemented with varying concentrations of RA (lO-iu to lO-'M dissolved in 
DMSO/DMEM) or equivalent volume of solvent as control. Embryos were 
cultured for 48 hours in a roller incubator at 38°C, with continuous gassing as 
described in section 4.3.2. At the end of the culture period, yolk sac circulatory 
and allantois development were immediately graded according to a well-adopted 
morphological scoring system (Van Maele-Fabry et al, 1990). Embryos were then 
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freed from extra-embryonic tissues and fixed in ice-cold 4% paraformaldehyde in 
PBS overnight. The fixative was removed by washing the embryos in PBS three 
times for 15 minutes in each step. Embryos were cleared in 50% glycerol in H2O 
for 1 hour and then changed to 75% glycerol. The development of another 15 
features, as detailed in section 5.3.3 and Table 5.1，was graded. 
5.3.3 Morphological scoring system 
To quantitate the development of rat embryos in different treatment 
groups, embryos were graded by a morphological scoring system developed by 
Van Maele-Fabry et al. (1990). Development of embryos were graded in 17 
features, including yolk sac circulatory system, allantois, flexion, heart, caudal 
neural tube, hindbrain, midbrain, forebrain, otic system, optic system, olfactory 
system, branchial bars, maxillary process, mandibular process, forelimb, hindlimb 
and number of somites. Each parameter is divided into several grades, ranging 
from Grade 0-3 to Grade 0-6 (please refer to Table 5.1 for details). The 
Van-Maele-Fabry et al. (1990) is developed for mouse embryos, but can be 
employed for rat embryos, with modification in the scoring system for somite 
number according to Brown and Fabro (1981). The score for the 17 features was 
added together to become the total morphological score for each embryo. Between 
8 to 12 embryos were analyzed for each group. 
5.3.4 Statistical analyses 
First, the score value of individual morphological feature or the total 
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morphological score of embryos cultured in medium supplemented with varying 
concentrations of RA was tested for any significant difference from embryos of 
the RA control group developing in the same glycemic conditions by using 
Independent Samples t-test. Second, the score value of individual morphological 
feature or the total morphological score of embryos cultured in medium 
supplemented with varying concentrations of RA and 3 or 4 mg/ml D-glucose was 
tested for any significant difference from embryos cultured in medium without 
addition of RA or D-glucose by using Independent Samples t-test. Next, to 
determine whether there was any dose-dependent relationship between the 
concentration of RA supplemented in the culture medium and the score value of 
individual feature or the total morphological score for embryos under the same 
glycemic conditions, Spearman's Rank Correlation was employed to test whether 
there was any linear correlation between these 2 non-parametric variables. This 
test will generate a Spearman's rank correlation coefficient � with values 
ranging from +1 to -1. If the value is close to +1, that means there is a strong 
positive linear relationship between the 2 variables. In contrast, if the value is 
close to -1，it means that there is a strong negative linear relationship between the 
2 variables. A value equals to zero means that there is no linear correlation 
between the 2 variables. The t-test is then used to establish if the correlation . 
coefficient is significantly different from zero, with a p-value showing the • 
significance level of linearity. 
All statistical analyses were performed using SPSS software (SPSS), 
with statistical significance level set as/? < 0.05. 
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5.4 RESULTS 
5.4.1 Supplementation with RA rescued embryos from hyperglyce-
mia-induced malformations 
The photographs of rat embryos cultured in varying concentrations of 
D-glucose and RA were presented in Figure 5.1. The score value for each of the 
17 features and also the total morphological score for embryos in different 
treatment groups were summarized in Table 5.1，with results of statistical analyses 
by Independent Samples t-test summarized in Table 5.2 and Table 5.3 and by 
Spearman's Rank Correlation summarized in Table 5.4. The result of total 
morphological score was presented in Graph 5.1. 
Without extra D-glucose, embryos cultured in varying concentrations 
of RA (Figures 5.IB to 5.IE) showed no distinguishable morphological 
differences from control embryos (Figure 5.1 A). There were no significant 
differences between RA-treated and control groups in all 17 features and the total 
morphological score (Table 5.2, Graph 5.1), showing that the dosages of RA 
applied were non-teratogenic. ”. 
Embryos cultured in hyperglycemic conditions exhibited retarded 
development and malformations, with malformations more obvious and severe in 
the 4 mg/ml D-glucose group (Figure 5.IK) than the 3 mg/ml D-glucose group 
(Figure 5.IF). The total morphological score together with the score value of 13 
out of 17 features for the 3 mg/ml D-glucose group and 15 out of 17 features for 
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the 4 mg/ml D-glucose group were significantly less than the Control D-glucose 
group (Table 5.3, Graph 5.1). However, when glucose-treated groups were 
supplemented with RA, there was a dose-dependent rescue on the embryos 
(Figures 5.IF to 5.10). As low as lO'^ ^M RA, there was prominent improvement 
in growth and morphology of the embryos in both 3 and 4 mg/ml D-glucose 
groups (compare Figure 5.1G with 5.IF, Figure 5.1L with 5.IK), although the 
degree of improvement had not yet reached a statistically significant level (Table 
5.2, Graph 5.1). However, as the dose increased to lO'^ M RA, the total 
morphological score together with the score value of 11 out of 17 features for the 
3 mg/ml D-glucose group and 8 out of 17 features for the 4 mg/ml D-glucose 
group were significantly increased in comparison to the Control RA group 
cultured in the same glycemic condition (Table 5.2, Graph 5.1). The increase was 
so prominent that the score value of 10 out of those 11 features in the 3 mg/ml 
D-glucose group and 4 out of those 8 features in the 4 mg/ml D-glucose group no 
longer showed any significant differences from control embryos cultured in 
medium without added RA and D-glucose (Table 5.3，Graph 5.1). As the dose of 
RA increased further, more and more features were restored to normal 
morphology. Results of statistical analyses by Spearman's Rank Correlation 
showed that there was a dose-dependent increase in the total morphological score 
together with the score value of 12 out of 17 features for the 3 mg/ml D-glucose -
group and 14 out of 17 features in the 4 mg/ml D-glucose group as the 
concentration of RA increased (Table 5.4, Graph 5.1). 
Taken together, results showed that exogenous supplementation with 
RA could exert a dose-dependent rescue of the embryos from 
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5.5 DISCUSSION 
Results of this chapter have demonstrated that elevated glucose 
induced malformations in rat embryos cultured in vitro, but exogenous addition of 
RA could successfully ameliorate or abolish the adverse effect of hyperglycemia 
and rescued embryos from developing malformations. These findings therefore 
support our hypothesis that reduction in RA synthesis caused by elevated glucose 
indeed play a role in increasing the risk of malformations in the embryo. 
How does reduction in RA synthesis predispose embryos to different 
types of malformations that are commonly observed in diabetic pregnancy? It is 
possible that reduced levels of RA may affect the expression of some RA-related 
genes that are involved in the pathogenic pathway of certain types of 
malformations associated with diabetic pregnancy. Some RA-related genes may 
possess RARE in their promoter region. RARE is basically a consensus sequence 
that allows the binding of the RAR and RXR heterodimers to the promoter region 
of the target genes. Upon binding of RA-RA receptor complex to the RARE, it 
will trigger activation or suppression of the target genes. Hence, if a gene 
possesses RARE in its promoter region, transcription of this gene will most likely •. 
be affected by the presence of RA. For example, PaxS is a member of the paired -
box family of transcription factors. It is expressed in the neural tube, neural crest 
cells and somites (Goulding et al., 1991). Homozygous Splotch mutant embryos 
with mutations of Pax3 die in utero and develop neural tube defects and heart 
septal defects (Epstein et al., 1991; Conway et al., 1997). Pax2> is found to be 
significantly down-regulated in mouse embryos under diabetic and hyperglycemic 
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conditions (Phelan et al, 1997; Fine et al, 1999). It has been shown that PaxS is 
involved in inhibition of p53-mediated apoptosis (Pani et al., 2002; Underwood et 
al, 2007). Thus reduction in Pax3 will lead to an increase in apoptosis in the 
neuroepithelium, thereby predisposing embryos to neural tube defects. However, 
the underlying mechanism for the down-regulation of PaxS expression remains 
unclear. Recently, a RARE is found to be located at the promoter region of PaxS 
(Kennedy et al, 2009), implying that the transcription of this gene can be directly 
regulated by RA levels. Thus, it is tempting to suggest that down-regulation of 
PaxS in embryos of diabetic mice is caused by reduction of RA levels'. 
RA is an important signaling molecule indispensible for embryo 
development. Homologous deletion of Raldh2 causes embryonic lethality and 
embryos develop malformations of many organ systems, such as the pancreas, 
heart, lung and limb buds. Maternal supplementation of Raldh2{-/-) mouse 
embryos with low doses of RA could restore normal development of these organs 
(Niederreither et al., 2001; Mic et al, 2004; Martin et al, 2005; Chen et al., 2007). 
Some of the down-stream effector genes in the retinoid signaling pathway have 
been identified. For example, Hb9 or Hlxb9 is expressed in the pancreatic 
epithelial progenitor cells and later becomes restricted to the P-cell lineage. It is 
required for dorsal pancreatic development. Although it is unclear whether Hb9 • 
possess RARE, Hb9 expressing cells are severely reduced in Raldh2(-/-) mouse 
embryos and supplementation with low doses of RA could rescue early pancreatic 
development (Martin et al, 2005). Thus, it is suggested that the interaction 
between RA and Hb9 is important for pancreas development. It has been shown in 
humans that HLXB9 is the main locus for dominantly inherited sacral agenesis 
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(Ross et al., 1998). Interestingly, sacral agenesis, also commonly called caudal 
agenesis or caudal regression, is found to be the malformation most highly 
associated with maternal diabetes (Martinez-Frias, 1994.). Thus, it is possible that 
reduction of RA levels in embryos of diabetic pregnancy may down-regulate Hb9 
and increases the risk of pancreatic malformation and sacral agenesis. 
As mentioned before, the types of malformations that show increased 
risk in diabetic pregnancy is also similar to those with disrupted levels of vitamin 
A or RA. Disrupted levels involve both excess and deficiency. RA levels in the 
embryo are tightly regulated by RA synthesizing (Raldh) and catabolizing (Cyp26) 
enzymes, which are expressed in complementary non-overlapping domains 
(Swindell et al., 1999). While Raldh expresses in tissues that require RA for 
proper development, Cyp26 expresses in tissues that have to be devoid of the 
teratogenic effect of RA. For example, Cyp26al expresses specifically in the tail 
bud region of the embryo (Fujii et al., 1997). It has been shown by our laboratory 
that a teratogenic dose of RA would down-regulate Wnt3a, a gene indispensible 
for tail bud development (Takada et al., 1994) and induced apoptosis, thereby 
leading to caudal agenesis (Shum et al., 1999). Our laboratory has also found that 
in embryos of diabetic mice, Cyp26al is significantly down-regulated. As a result, . 
there is a reduction in RA catabolizing activity in the tail bud and thus the embryo • 
becomes more susceptible to the teratogenic effect of RA in inducing caudal 
agenesis (Lee, 2007). Among the 3 isoforms of Cyp26, only the expression of 
Cyp26al, but not Cyp26bl and Cyp26cl, is down-regulated by diabetic or 
hyperglycemic conditions (unpublished data). Interestingly, RARE has been 
identified only in Cyp26al (Zhang et al., 2010). It has been shown that Cyp26al 
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expression can be positively regulated by RA and vitamin A levels (Yamamoto et 
al., 2000; Ozpolat et al.，2005). Thus, we hypothesize that a general reduction in 
RA synthesis in the embryo may down-regulate Cyp26al, which leads to ectopic 
RA signaling in specific tissues such as the tail bud, and therefore increasing the 
risk of caudal regression and other specific types of malformations. For example, 
Cyp26al expresses in the branchial arch region and down-regulation of Cyp26al 
may account for the increased susceptibility to the teratogenic effect of RA in 
inducing cleft palate in diabetic pregnancy (Chan et al., 2002). 
Taken together, results of this chapter support that reduction of RA 
synthesis in embryos caused by elevated glucose plays a role in increasing the risk 
of malformations. To further investigate the molecular mechanism, it will be 
interesting to determine whether RA-related genes are indeed affected in diabetic 
or hyperglycemic conditions. 
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Figure 5.1 Morphology of rat embryos cultured for 48 hours in medium 
supplemented with varying concentrations of D-glucose and 
RA or the respective solvent as control. 
A. Morphology of the rat embryo cultured in medium added with the respective 
solvent of D-glucose (Control D-glucose) and RA (Control RA). The 
embryo developed normally. 
B. Morphology of the rat embryo cultured in Control D-glucose and lO'^ ^M RA. 
The embryo showed no distinguishable morphological differences from the 
control group in A. The low dose of lO'^ ^M RA did not cause 叩y 
malformation in the embryo developed in normoglycemic condition. 
Q 
C. Morphology of the rat embryo cultured in Control D-glucose and 10" M RA. 
The embryo showed no distinguishable morphological differences from the 
control group in A. The low dose of lO'^ M RA did not cause any 
malformation in the embryo developed in normoglycemic condition. 
D. Morphology of the rat embryo cultured in Control D-glucose and lO'^ M RA. 
The embryo showed no distinguishable morphological differences from the 
control group in A. The low dose of lO'^ M RA did not cause any 
malformation in the embryo developed in normoglycemic condition. 
E. Morphology of the rat embryo cultured in Control D-glucose and 10" M RA. 
The embryo showed no distinguishable morphological differences from the 
control group in A. Even increasing the dose of RA to lO'^ M did not cause 
any malformation in the embryo developed in normoglycemic condition. 
F. Morphology of the rat embryo cultured in 3 mg/ml D-glucose and Control 
RA. Without RA supplementation, D-glucose could result in retarded 
development of the embryo. Malformations were observed in many 
structures, especially in the cranial and caudal regions. 
G Morphology of the rat embryo cultured in 3 mg/ml D-glucose and 
RA. Supplementation with 10'^ ^M RA could improve the development of the 
glucose-treated embryo. As compared with the Control RA embryo in F, 
hyperglycemia-induced caudal regression was ameliorated. 
H. Morphology of the rat embryo cultured in 3 mg/ml D-glucose and lO'^ M RA. 
As the dose of RA increased to lO'^ M, there was prominent improvement in 
most of the morphological features of the embryo in comparison to the 
glucose-treated Control RA embryo in R 
I. Morphology of the rat embryo cultured in 3 mg/ml D-glucose and lO'^ M RA. 
n 
As the dose of RA further increased to 10 M RA, embryos were rescued 
from most of the hyperglycemia-induced malformations. The morphology of 
the embryo was very similar to the control group in A. 
n 
J. Morphology of the rat embryo cultured in 3 mg/ml D-glucose and 10" M RA. 
Supplementation with lO'^ M RA could restore normal development of the 
glucose-treated embryo. 
K. Morphology of the rat embryo cultured in 4 mg/ml D-glucose and Control 
RA. Without RA supplementation, development of the embryo in 4 mg/ml 
D-glucose group was affected to a greater extent than the embryo in 3 mg/ml 
D-glucose group as shown in R Malformations developed throughout the 
whole body. There was failure in axial rotation and the brain was poorly 
developed. 
L. Morphology of the rat embryo cultured in 4 mg/ml D-glucose and lO'^ ^M 
RA. Supplementation with lO'^ ^M RA could prominently improve the 
development of the glucose-treated embryo. Axial rotation was restored. 
M. Morphology of the rat embryo cultured in 4 mg/ml D-glucose and lO'^ M RA. 
Most of the hyperglycemia-induced malformations were ameliorated in 
embryos supplemented with lO'^ M RA. 
N. Morphology of the rat embryo cultured in 4 mg/ml D-glucose and lO'^ M RA. ‘ 
Further increase in RA concentrations to lO'^ M could rescue the embryo 
from most of the hyperglycemia-induced malformations. 
O. Morphology of the rat embryo cultured in 4 mg/ml D-glucose and lO'^ M RA. 
The development of the glucose-treated embryo was highly similar to the 
control group in A, showing that supplementation with lO'^ M RA could 
abolish the adverse effect of hyperglycemia and rescued embryos from 
developing malformations. 















































Graph 5.1 Total morphological score of rat embryos cultured for 48 
hours in medium supplemented with varying 
concentrations of RA and D-glucose or the respective 









:: 40 ro 
Co) 
'5b 
















Sample size in parentheses .. 
Data was analyzed by Independent Samples t-test. 
D Control RA 
m 10-1<M RA 
l\'f:J 10-'M RA 
~ 10-8M RA 
• 10-7M RA 
* p < 0.001; t p < 0.01 vs. Control RA in the same glycemic condition 
Data was analyzed by Spearman's Rank Correlation. 
3 mg/ml D-glucose group: 
Spearman's rank correlation coefficient rs = 0.699, p < 0.001 
4 mg/ml D-glucose group: 





Chapter 6: Conclusion and Future Perspectives 
6.1 CONCLUSION AND FUTURE PERSPECTIVES 
As mentioned in Chapter 1, babies of diabetic mothers show increased 
risk of having congenital malformations. Many types of malformations that show 
elevated risk in diabetic pregnancy are similar to those observed in cases caused 
by disrupted levels of vitamin A or its bio active metabolite RA. The aim of this 
thesis was to determine whether RA synthesis was dysregulated under diabetic or 
hyperglycemic conditions that might play a role in increasing the risk of 
malformations. 
In Chapter 3, the gene expression level of the 3 isoforms of RA 
synthesizing enzymes, Raldhl, Raldh2 and RaldhS, was examined. It was found 
that the expression of all 3 isoforms was significantly down-regulated in embryos 
of diabetic mice from primitive streak stage to mid-gestation, which is an 
important period for organogenesis. The result was confirmed both qualitatively 
and quantitatively by in situ hybridization and real-time quantitative RT-PCR. 
Among these 3 isoforms, Raldh2 is the key and dominant RA synthesizing 
enzyme, expressing in a wide range of tissues, whereas Raldhl and RaldhS are 
expressed in very restricted domains. Concomitant with a down-regulation of the • 
gene expression level, the RA synthesizing activity of Raldh2 enzymes, measured • 
by an in vitro assay, was also found to be significantly reduced in embryos of 
diabetic mice. 
To follow on, in Chapter 4, an in vivo experiment was first conducted 
to specifically reduce the maternal blood glucose of diabetic mice to a 
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sub-diabetic level via induction of renal glucosuria by phlorizin treatment. 
Concomitantly, it was found that RA synthesis in embryos of diabetic mice, 
measured in terms of both the gene expression level of Raldhl, Raldh2 and 
RaldhS and the in vitro RA synthesizing activity of Raldh2 enzymes, was 
normalized to a level similar to that of embryos of non-diabetic mice. These 
results strongly support that elevated glucose is a critical factor in the maternal 
diabetic milieu that reduces RA synthesis in embryos of diabetic mice. Moreover, 
by employing an in vitro approach to culture rat embryos in medium 
supplemented with varying concentrations of D-glucose, it was demonstrated that 
elevated glucose could reduce RA synthesis in the embryo in a dose-dependent 
manner. 
To further decipher the linkage among hyperglycemia, RA levels in the 
embryo and susceptibility to congenital malformations, an in vitro approach was 
employed. In Chapter 4, it was shown that rat embryos cultured in hyperglycemic 
conditions resulted in reduction of RA synthesis and congenital malformations. 
Thus, in Chapter 5，a rescue experiment was conducted by supplementing rat 
embryos cultured in hyperglycemic conditions with varying concentrations of low 
doses of RA. Indeed, it was found that exogenous addition of RA could prevent • 
embryos cultured in hyperglycemic conditions from developing anomalies. • 
Moreover, the rescue effect was dose-dependent, such that the higher the dose of 
RA, the more prominent the rescue effect. 
Although results of this thesis strongly support that elevated glucose in 
the maternal diabetic milieu causes reduction of RA synthesis in the mouse 
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embryo and thus increases the susceptibility to malformations, the underlying 
mechanism of how glucose reduces RA synthesis in the embryo remains to be 
determined. Apart from RA, many factors are altered in maternal diabetes and are 
shown to be involved in diabetic embryopathy. These factors may act upstream or 
downstream of RA synthesis. For instance, increased oxidative stress is induced in 
embryos exposed to high glucose (Eriksson and Borg, 1993; Trocino et al., 1995; 
Yang et al., 1997). However, animal studies have shown that in vivo or in vitro 
supplementation with free radical scavenging enzymes and antioxidants can 
rescue embryos in diabetic or hyperglycemic conditions from developing 
malformations (Eriksson and Borg, 1991; Hagay et al., 1995; Eriksson and Siman 
1996; Siman and Eriksson 1997a，b; Wentzel et al., 1997; Wentzel and Eriksson 
1998), thus supporting that excess oxidative stress plays an important role in 
diabetic embryopathy. Excess free oxygen radicals will increase lipid peroxidation 
(Wentzel et al., 1999; Cederberg et al., 2001). It has been demonstrated that 
aldehydes generated from lipid peroxidation inhibits embryonic RA synthesis 
(Chen and Juchau, 1998). Thus, it is tempting to suggest that oxidative stress 
induced by high glucose increases lipid peroxidation and thus reduces RA 
synthesis in the embryo, thereby leading to increased susceptibility to 
malformations in diabetic pregnancy. . 
To test the above hypothesis, the association between oxidative stress 
and RA synthesis should be investigated. Several experiments can be conducted. 
First, normal pregnant mice can be administered in vivo with substances that are 
known to induce oxidative stress in the embryo, e.g. antimycin A (Morgan et al., 
2008b) and tertiary-butyl hydroperoxide (tBH) (Gardiner al., 1994) or rat embryos 
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cultured in vitro can be supplemented with oxidative stress-inducing agents, such 
as 8-iso-PGF(2a) (Wentzel and Eriksson, 2002), in the culture medium. After in 
utero treatment or in vitro culture, embryos can be collected for analysis of 
malformations, lipid peroxidation and RA synthesis, including the Raldh gene 
expression by in situ hybridization and real-time quantitative RT-PCR, the Raldh 
protein expression by immunohistochemistry and western blotting, and the RA 
synthesizing activity of Raldh enzyme by using the in vitro bioassay as described 
in this thesis. The RA concentration in the embryo can also be measured by the 
RA-responsive cell line. If RA synthesis is in the downstream pathway of 
oxidative stress, it is expected that inducing oxidative stress in normal embryos 
will reduce RA synthesis and thus RA levels in the embryo. If this hypothesis is 
true, then in vitro supplementation with low doses of RA to rat embryos cultured 
in medium containing oxidative-stress inducing agents should prevent embryos 
from malformations and normalize RA synthesis and RA levels. 
As mentioned earlier, alleviation of oxidative stress can rescue 
embryos of diabetic animals from developing malformations. Thus, to directly test 
the relationship between oxidative stress and RA synthesis in embryos of diabetic 
pregnancy, diabetic pregnant mice can be administered with antioxidants, such as • 
butylated hydroxytoluene, vitamin C and vitamin E, which have been • 
demonstrated to effectively reduce lipid peroxidation and malformations in the 
embryos (Eriksson and Siman, 1996; Siman and Eriksson 1997a,b). If RA 
synthesis is acting downstream of oxidative stress, then alleviation of oxidative 
stress should normalize RA synthesis in embryos of diabetic mice. 
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To conclude，results of this thesis support that dysregulation of RA 
synthesis increases the susceptibility of mouse embryos to congenital 
malformations in diabetic pregnancy. This may shed light on explaining why 
many types of malformations that show increased incidences in diabetic 
pregnancy are similar to those caused by disrupted levels of RA. I hope that the 
finding of this thesis can provide new insights for preventing the risk of birth 
defects in diabetic pregnancy. 
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